StudyFinder
Search Results
Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.
Search all categories
631 Study Matches
In-Home Adjustment of New Spinal Cord Injury Caregivers
Perrin, Paul, B - pperrin@vcu.edu
Perrin, Paul, B
N/A
NCT03244098
HM20009566
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
SCI Patient Inclusion Criteria:
• have a telephone in the home or cellular phone and are able to talk on the phone in English
• are able to provide informed consent
• demonstrate a clinician-rated loss in motor/sensory function on the ASIA scale (i.e., have a spinal cord injury) Caregiver
Inclusion Criteria:
• have a telephone in the home or cellular phone and are able to talk on the phone in English
• are able to provide informed consent
• are a primary caregiver of the individual with SCI
• Caregivers with scores below 10 on the literacy screen will identify a family member or friend to review the guidebook with the caregiver. If no one is identified, the TAP clinician will review the materials with the caregiver and function in that additional capacity
Exclusion Criteria:
• individual with SCI receives his/her primary care from a professional caregiver or other individual outside of the household besides the primary caregiver
• individuals with SCI or caregivers with known current uncontrolled substance dependence, aphasia, anosognosia (deficit in self-awareness), or treatment due to known self-inflicted injury
• individuals living alone
• prisoners
• SCI patient without decision making capacity to consent
Behavioral: Transition Assistance Program
Spinal Cord Injuries, External Causes of Injury and Poisoning (800-999)
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 1 location
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Virginia Commonwealth University Richmond, Virginia |
Genome Transplant Dynamics (GTD NIH)
Sean T Agbor-Enoh, M.D. - agborenohst@mail.nih.gov
Shah, Keyur, B
N/A
NCT02423070
HM20004684
Show full eligibility criteria
Hide eligibility criteria
* INCLUSION CRITERIA:
* Lung and heart transplant candidates. Dual organ transplants such as those that include lung or heart PLUS any other organ are also considered for enrollment.
* Subjects who have undergone lung or heart transplants and are within 3 months of transplantation.
* 14 years and older
* Able to understand and be willing to sign the informed consent form. Subjects undergoing a double transplant will sign a single consent.
* Retransplant candidates will be considered as a new transplants. These subjects will be approached for enrollment and if they consent to participate, they will be assigned a different SSPIN.
EXCLUSION CRITERIA:
-Pregnancy
Thoracic Organ Transplantation
Cell-free DNA, Acute Rejection, Thoracic Organ Transplantation, Non-Invasive Testing, Chronic Rejection, Natural History
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 6 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| INOVA Fairfax Medical Falls Church, Virginia | Steven Nathan, M.D. - (steven.nathan@inova.org) |
| Johns Hopkins University Baltimore, Maryland | Jonathan Orens, M.D. - (jorens@jhmi.edu) |
| Medstar Washington Hospital Center Washington D.C., District of Columbia | |
| National Institutes of Health Clinical Center Bethesda, Maryland | For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) - (ccopr@nih.gov) |
| University of Maryland Baltimore, Maryland | |
| Virginia Commonwealth University Richmond, Virginia |
Myocardial Ischemia and Transfusion (MINT)
Jeffrey L Carson, MD - Jeffrey.Carson@Rutgers.edu
Kontos, Michael, C
Phase 3
NCT02981407
HM20010218
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
• 18 years of age or older
• Either ST segment elevation myocardial infarction or Non ST segment elevation myocardial infarction consistent with the 3rd Universal Definition of Myocardial Infarction criteria that occurs on admission or during the index hospitalization
• Hemoglobin concentration less than 10 g/dL at the time of random allocation
• Patient physician believes that both of the transfusion strategies are consistent with good medical care for the patient
Exclusion Criteria:
• Uncontrolled acute bleeding at the time of randomization defined as the need for uncrossed or non-type specific blood
• Decline blood transfusion
• Scheduled for cardiac surgery during the current admission
• Receiving only palliative treatment
• Known that follow-up will not be possible at 30 days
• Previously participated in MINT
• Currently enrolled in a competing study that interferes with the intervention or follow-up of MINT or enrolled in a competing study that has not been approved by the local Institutional Review Board
• Patient physician does not believe the patient is an appropriate candidate for the trial
Biological: Red Blood Cell Transfusion
Myocardial Infarction, Anemia
Red Blood Cell Transfusion, Anemia, Heart Disease, Cardiovascular Disease
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 133 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| AMITA Health Hinsdale, Illinois | |
| Albany Medical College Albany, New York | |
| Alexian Brothers Medical Center Elk Grove Village, Illinois | |
| Auckland City Hospital Grafton, Auckland | |
| Aultman Hospital Canton, Ohio | Jeannie Archinai |
| Baylor St Luke's Medical Center Houston, Texas | |
| Beth Israel Deaconess Medical Center Boston, Massachusetts | |
| Boston Medical Center Boston, Massachusetts | |
| CH Chartres - Chartres Chartres, | |
| CHRU Tours -Hôpital Trousseau Chambray-lès-Tours, | |
| CHU Arnaud de Villeneuve - Montpellier Montpellier, | |
| CHU Nancy Nancy, | |
| CHU Poitiers - Poitiers Poitiers, | |
| CHU le Bocage - Dijon Dijon, | |
| Central Arkansas Veterans Healthcare System Little Rock, Arkansas | |
| Centre Hosp. Universitaire de Montréal Montréal, Quebec | |
| Centre Hospitalier Sud Francilien Corbeil-Essonnes, | |
| Centre Hospitalier Universitaire de Lille Lille, | |
| Centre Hospitalier Universitaire de Sherbrooke Sherbrooke, Quebec | |
| Christchurch Hospital Christchurch, | |
| Concord Repatriation General Hospital Concord, | |
| Copper University Hospital Camden, New Jersey | |
| Danbury Hospital Danbury, Connecticut | |
| Durham Va Durham, North Carolina | |
| Essentia Health Duluth, Minnesota | |
| Flinders Medical Centre Bedford Park, South Australia | |
| Foothills Medical Centre Calgary, | |
| General Hospital Trois-Rivièrs Trois-Rivières, Quebec | |
| Gisborne Hospital Gisborne, | |
| Gosford Hospital Gosford, | |
| Greenville Health System Greenville, South Carolina | |
| Grey Nuns Community Hospital Edmonton, Alberta | |
| Hackensacjk University Medical Center Hackensack, New Jersey | |
| Hamilton Health Sciences Hamilton, Ontario | |
| Hamilton St. Joseph's Health Hamilton, Ontario | |
| Hopital Charles LeMoyne Greenfield Park, Quebec | |
| Hopital Europeen Georges-Pompidou Paris, | |
| Hopital Haut Leveque Pessac, | |
| Hopital La Pitie Salpetriere Paris, | |
| Hopital Pasteur Nice, | |
| Hopital Rangueil Toulouse, | |
| Hospital Agamenon Magalhães Recife, Pernambuco | |
| Hospital Cárdio Pulmonar Salvador, Bahia | |
| Hospital Felício Rocho Belo Horizonte, Minas Gerais | |
| Hospital Maternidade e Pronto Socorro Santa Lucia Poços de Caldas, Minas Gerais | |
| Hospital São Paulo São Paulo, | |
| Hospital Universitário Professor Edgard Santos Salvador, | |
| Hospital Vera Cruz Campinas, | |
| Hospital das Clinicas da UFU Uberlândia, | |
| Hospital de Base de Rio Preto São José Do Rio Preto, São Paulo | |
| Hospital de Base de Rio Preto São José Do Rio Preto, São Paulo | |
| Hospital de Clínicas da UFTM Uberaba, | |
| Hotel-Dieu de Levis Lévis, Quebec | |
| Hôpital BICHAT- APHP Paris, | |
| Hôpital Charles Nicolle- Rouen Rouen, | |
| Hôpital Lariboisière Paris, | |
| Hôpital Universitaire Carémeau (CHU Carémeau) Nîmes, | |
| Instituto Orizonti Belo Horizonte, | |
| Instituto de Cardiologia do RS Porto Alegre, | |
| Instituto de Ensino e Pesquisa do Hospital da Bahia Salvador, Estado de Bahia | |
| Instituto de Ensino e Pesquisa do Hospital do Coração do Brasil Brasília, | |
| Jersey Shore University Medical Neptune, New Jersey | |
| Jewish General Hospital Montreal, Quebec | |
| La Tronche Hôpital Michallon La Tronche, | |
| Lahey Hospital Burlington, Massachusetts | |
| Lancaster General Hospital Lancaster, Pennsylvania | |
| Lankenau Medical Center Wynnewood, Pennsylvania | |
| Lenox Hilll Hospital New York, New York | |
| Massachusetts General Hospital Boston, Massachusetts | |
| Mayo Clinic Rochester, Minnesota | |
| Medical College of Wisconsin - Froedtert Hospital Milwaukee, Wisconsin | Barbara Shimada-Krouwer, RN BSB |
| Memorial Hospital at Gulfport Gulfport, Mississippi | |
| Minneapolis Heart Institute (Foundation) Minneapolis, Minnesota | |
| Montefiore Medical Center The Bronx, New York | |
| Montreal General Hospital Montreal, Quebec | |
| NYP Brooklyn Methodist Brooklyn, New York | |
| NYU Langone Medical Center, Bellevue Hospital New York, New York | |
| Nelson Hospital Nelson, | |
| New York Presbyterian/Queens Flushing, New York | |
| North Shore University Hospital Manhasset, New York | |
| Northern Westchester Hospital Mount Kisco, New York | |
| Northwell Staten Island Hopsital Staten Island, New York | |
| PENN Presbyterian Medical Cente Philadelphia, Pennsylvania | |
| Pronto Socorro Cardiológico de Pernambuco Prof. Luiz Tavares- PROCAPE Recife, | |
| QE II Health Sciences Center Halifax, Nova Scotia | |
| Quebec Heart and Lung Institute Quebec, | |
| Regina General Hospital Regina, Saskatchewan | |
| Rhode Island Hospital Providence, Rhode Island | |
| Robert Wood Johnson University Hospital New Brunswick, New Jersey | Jeffrey L Carson, MD - (jeffrey.carson@rutgers.edu) |
| Rochester General Hospital Rochester, New York | |
| Royal Alexandra Hospital Edmonton, Alberta | |
| Royal Columbian Hospital New Westminster, British Columbia | |
| Royal Perth Hospital Perth, Western Australia | |
| Royal Victoria Hospital Montréal, Quebec | |
| Rush University Medical Center Chicago, Illinois | |
| Saint Luke's Mid America Heart Kansas City, Kansas | |
| Santa Casa de Marília Cascata, | |
| Sociedade Hospitalar Angelina Caron Centro, | |
| Southside Hospital Bay Shore, New York | |
| St. Boniface General Hospital Winnipeg, Manitoba | |
| St. Joseph Mercy Health System Ypsilanti, Michigan | |
| St. Joseph's Health Centre Hamilton, Ontario | |
| St. Michael's Hospital Toronto, Ontario | |
| Stony Brook Medicine Stony Brook, New York | |
| Sunnybrook Health Sciences Centre Toronto, Ontario | |
| Surrey Memorial Hospital Surrey, British Columbia | |
| Taranaki Hospital New Plymouth, | |
| The Memphis VAMC Memphis, Tennessee | |
| The Miriam Hospital Providence, Rhode Island | |
| The University of North Carolina at Chapel Hill Chapel Hill, North Carolina | |
| Thomas Jefferson University Philadelphia, Pennsylvania | |
| Tulane University School of Medicine New Orleans, Louisiana | |
| University Hospital - LHSC London, Ontario | |
| University of Alberta Hospital Edmonton, Alberta | |
| University of Arkansas Medical Sciences (UAMS) Hospital Little Rock, Arkansas | |
| University of Chicago Medical Center Chicago, Illinois | Mary Harris-Moreno |
| University of Louisville Louisville, Kentucky | |
| University of Michigan Ann Arbor, Michigan | |
| University of Minnesota Medical Center Fairview Minneapolis, Minnesota | |
| University of New Mexico Albuquerque, New Mexico | |
| University of Pittsburgh Medical Center Pittsburgh, Pennsylvania | |
| University of Rochester Rochester, New York | |
| University of Toledo Medical Center Toledo, Ohio | |
| University of Vermont Medical Center Burlington, Vermont | |
| VAGLAHS Los Angeles, California | |
| Vancouver General Hospital Vancouver, British Columbia | |
| Victoria Heart Institute Victoria, Ontario | |
| Victoria Hospital - LHSC London, Ontario | |
| Virginia Commonwealth University Richmond, Virginia | |
| WakeMed Health and Hospital Raleigh, North Carolina | |
| Washington University St Louis, Missouri | |
| Westchester Medical Center Valhalla, New York | |
| Whangarei Hospital Whangarei, |
SynCardia 70cc TAH-t for Destination Therapy (DT) (RA-540)
Judy Skroback, CIP, CRCP - jskroback@syncardia.com
Medalion, Benjamin
N/A
NCT02232659
HM20004553
Show full eligibility criteria
Hide eligibility criteria
Primary Arm
• Patients with ife-threatening, irreversible biventricular heart failure (Intermacs Patient Profile Classifications 1 - 4)
• Ineligible for cardiac transplantation (e.g., contraindication to immunosuppression, cancer, elevated panel reactive antibodies [PRAs]) as determined by the implanting center at time of implant screening assessment.
• On optimal medical management and failing to respond or failing DT VAD therapy (continuing to decline)
• Ambulatory without assistance
• Patients between 19 and 75 years of age
• Patients with Body Surface Area (BSA) of ? 1.7m2
• Sternum to T10 distance > 10cm OR adequate room in chest as determined by 3-D imaging assessment or by other standard clinical assessments
• Cardiac transplant-eligible patients
• Patients who cannot be adequately anticoagulated on the TAH-t
• Patients with insufficient space in the chest
• Patients on ECMO support
• Patients with Cirrhosis (evidenced by ultrasound, CT scan, or positive biopsy)
• Patients with Acute or Chronic Renal dysfunction (per Intermacs AE Definitions)
• Patients with cardiac cachexia (e.g., pre-albumin <17, fragility, and catabolic/anabolic imbalance)
• Patients with a comorbidity that has a poor prognosis of survival beyond six months
• Patients with insufficient social support or who have demonstrated non-compliance with medical instructions (as determined by the Principal Investigator) Secondary Arm
• Patients who are NOT eligible to participate in the Primary Arm
• Patients with life-threatening, irreversible biventricular heart failure (Intermacs Patient Profile Classifications 1 - 7)
• Ineligible for cardiac transplantation (as determined by the implanting center at time of implant screening assessment).
• On optimal medical management and failing to respond or failing DT VAD therapy (continuing to decline)
• Patients 19 years of age or older
• Sternum to T10 distance > 10cm OR adequate room in chest as determined by 3-D imaging assessment or by other standard clinical assessments
• Patients who are less than 19 years old
• Cardiac transplant-eligible patients
• Patients with Cirrhosis (evidenced by ultrasound, CT scan, or positive biopsy)
• Patients with Chronic Renal dysfunction (per Intermacs AE Definitions)
• Patients with insufficient space in the chest
• Patients who cannot be adequately anticoagulated on the TAH-t
• Patients with insufficient social support or who have demonstrated non-compliance with medical instructions (as determined by the Principal Investigator)
Inclusion Criteria:
• Patients with ife-threatening, irreversible biventricular heart failure (Intermacs Patient Profile Classifications 1 - 4)
• Ineligible for cardiac transplantation (e.g., contraindication to immunosuppression, cancer, elevated panel reactive antibodies [PRAs]) as determined by the implanting center at time of implant screening assessment.
• On optimal medical management and failing to respond or failing DT VAD therapy (continuing to decline)
• Ambulatory without assistance
• Patients between 19 and 75 years of age
• Patients with Body Surface Area (BSA) of ? 1.7m2
• Sternum to T10 distance > 10cm OR adequate room in chest as determined by 3-D imaging assessment or by other standard clinical assessments
Exclusion Criteria:
• Cardiac transplant-eligible patients
• Patients who cannot be adequately anticoagulated on the TAH-t
• Patients with insufficient space in the chest
• Patients on ECMO support
• Patients with Cirrhosis (evidenced by ultrasound, CT scan, or positive biopsy)
• Patients with Acute or Chronic Renal dysfunction (per Intermacs AE Definitions)
• Patients with cardiac cachexia (e.g., pre-albumin <17, fragility, and catabolic/anabolic imbalance)
• Patients with a comorbidity that has a poor prognosis of survival beyond six months
• Patients with insufficient social support or who have demonstrated non-compliance with medical instructions (as determined by the Principal Investigator) Secondary Arm
Inclusion Criteria:
• Patients who are NOT eligible to participate in the Primary Arm
• Patients with life-threatening, irreversible biventricular heart failure (Intermacs Patient Profile Classifications 1 - 7)
• Ineligible for cardiac transplantation (as determined by the implanting center at time of implant screening assessment).
• On optimal medical management and failing to respond or failing DT VAD therapy (continuing to decline)
• Patients 19 years of age or older
• Sternum to T10 distance > 10cm OR adequate room in chest as determined by 3-D imaging assessment or by other standard clinical assessments
Exclusion Criteria:
• Patients who are less than 19 years old
• Cardiac transplant-eligible patients
• Patients with Cirrhosis (evidenced by ultrasound, CT scan, or positive biopsy)
• Patients with Chronic Renal dysfunction (per Intermacs AE Definitions)
• Patients with insufficient space in the chest
• Patients who cannot be adequately anticoagulated on the TAH-t
• Patients with insufficient social support or who have demonstrated non-compliance with medical instructions (as determined by the Principal Investigator)
Device: 70cc TAH-t for Destination Therapy
Life-threatening, Biventricular Heart Failure, Ineligible for Cardiac Transplant
SynCardia, Total Artificial Heart, Biventricular heart failure, Ineligible for cardiac transplant
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 7 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Banner University Medical Center Phoenix, Arizona | |
| Banner University Medical Center Phoenix Phoenix, Arizona | |
| Cedars-Sinai Medical Center Los Angeles, California | |
| Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin | |
| Integris Baptist Medical Center Oklahoma City, Oklahoma | |
| Memorial Hermann Hospital Houston, Texas | |
| Virginia Commonwealth University Richmond, Virginia |
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Lisa Erickson, MPH - 10-CBA@ndmp.org
McCarty, John, M.
N/A
NCT01351545
HM13913
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* Disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment
* Signed informed consent (and signed assent, if applicable) obtained prior to study enrollment
* Pediatric and adult patients of any age
Exclusion Criteria:
* Patients who are receiving only licensed CBUs
* Cord blood transplant recipients at international transplant centers
* Patients who are enrolled on another IND protocol to access the unlicensed CBU(s)
* Patients whose selected unlicensed CBU(s) will be more than minimally manipulated DRUG: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)
Hematologic Malignancies, Inherited Disorders of Metabolism, Inherited Abnormalities of Platelets, Histiocytic Disorders, Acute Myelogenous Leukemia (AML or ANLL), Acute Lymphoblastic Leukemia (ALL), Other Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases, Other Leukemia, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma/ Plasma Cell Disorder (PCD), Inherited Abnormalities of Erythrocyte Differentiation or Function, Disorders of the Immune System, Autoimmune Diseases, Severe Aplastic Anemia
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 141 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| AdventHealth Orlando Orlando, Florida | Rushang Patel, MD - (rushang.patel.md@adventhealth.com) |
| Advocate Lutheran General Hospital Park Ridge, Illinois | |
| All Children's Hospital St. Petersburg, Florida | Deepakbabu Chellapandian, MD - (dchella2@jhmi.edu) |
| Amarillo Blood and Marrow Transplant Program Amarillo, Texas | |
| Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois | Sonali Chaudhury, MD - (schaudhury@luriechildrens.org) |
| Arkansas Children's Hospital Little Rock, Arkansas | Jason Farrar, MD - (JEFarrar@uams.edu) |
| Avera Transplant Institute Sioux Falls, South Dakota | Waqas Jehangir, MD, FACP - (waqas.jehangir@avera.org) |
| Banner MD Anderson Cancer Center Gilbert, Arizona | September Mitchell, RN - (september.mitchell@bannerhealth.com) Rajneesh Nath, MD - (rajneesh.nath@bannerhealth.com) |
| Beth Israel Deaconess Boston, Connecticut | |
| Cardinal Glennon Children's Medical Center St Louis, Missouri | Deepika Bhatla, MD - (dbhatla@slu.edu) |
| Children's Healthcare of Atlanta Atlanta, Georgia | Ann Haight, MD - (Ann.haight@choa.org) |
| Children's Hospital Colorado Aurora, Colorado | Michael Verneris, MD - (MICHAEL.VERNERIS@CUANSCHUTZ.EDU) |
| Children's Hospital and Research Center of Oakland Oakland, California | Mark Walters, MD - (mwalters@mail.cho.org) |
| Children's Hospital at Montefiore The Bronx, New York | Mahvish Rahim, MD - (mrahim@montefiore.org) |
| Children's Hospital of Los Angeles Los Angeles, California | Neena Kapoor, MD - (nkapoor@chla.usc.edu) |
| Children's Hospital of Michigan Detroit, Michigan | Sureyya Savasan, MD - (ssavasan@med.wayne.edu) |
| Children's Hospital of New Orleans/LSUHSC New Orleans, Louisiana | Lolie Yu, MD - (lyu@lsuhsc.edu) |
| Children's Hospital of Orange County (CHOC) Orange, California | Rishikesh Chavan, MD - (rishikesh.chavan@choc.org) |
| Children's Hospital of Philadelphia Philadelphia, Pennsylvania | Nancy Bunin, MD - (buninn@email.chop.edu) |
| Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania | Paul Szabolcs, MD - (Paul.szabolcs@chp.edu) |
| Children's Hospital of Wisconsin Milwaukee, Wisconsin | David Margolis, MD - (dmargoli@mcw.edu) |
| Children's Medical Center Dallas Dallas, Texas | Victor Aquino, MD - (Victor.aquino@utsouthwestern.edu) |
| Children's Mercy Hospital and Clinics Kansas City, Missouri | |
| Children's National Medical Center Washington D.C., District of Columbia | David Jacobsohn, MD - (dajacobs@childrensnational.org) |
| Childrens Hospital Medical Center of Akron Akron, Ohio | Megan Sampson, MD - (msampson@akronchildrens.org) |
| Cincinnati Children's Hospital Cincinnati, Ohio | Stella Davies, MD - (stella.davies@cchmc.org) |
| City of Hope Duarte, California | Monzr Al Malki, MD - (malmalki@coh.org) |
| Cleveland Clinic Cleveland, Ohio | Craig Sauter, MD - (sauterc@ccf.org) |
| Cohen Children's Medical Center of New York New Hyde Park, New York | Jonathan Fish, MD - (jfish1@nshs.edu) |
| Columbia University Medical Center - Morgan Stanley Children's Hospital New York, New York | Monica Bhatia, MD - (mb2476@columbia.edu) |
| Cook Children's Hospital Fort Worth, Texas | Gretchen Eames, MD - (gretchen.eames@cookchildrens.org) |
| Dana Farber Cancer Institute Boston, Massachusetts | Corey Cutler, MD - (cscutler@partners.org) |
| Duke University Medical Center Durham, North Carolina | Joanne Kurtzberg, MD - (kurtz001@mc.duke.edu) |
| Emory University Hospital Atlanta, Georgia | |
| Florida Center for Pediatric Cellular Therapy Orlando, Florida | Susan Kelly, MD - (susan.kelly.md@flhosp.org) |
| Fred Hutchinson Cancer Research Center Seattle, Washington | Ann Dahlberg, MD - (adahlber@fredhutch.org) |
| Greenebaum Cancer Center - University of Maryland Baltimore, Maryland | |
| H Lee Moffitt Cancer Center Tampa, Florida | |
| Hackensack University Medical Center Hackensack, New Jersey | Alfred Gillio, MD - (agillio@humed.com) |
| Helen DeVos Children's Hospital Grand Rapids, Michigan | Troy Quigg, MD - (troy.quigg@spectrumhealth.org) |
| Henry Ford Health System Detroit, Michigan | Nalini Janakiraman, MD - (njanaki1@hfhs.org) |
| Indiana Blood & Marrow Transplantation Beech Grove, Indiana | Luke Akard, MD - (lakard@ibmtindy.com) |
| Indiana University/Riley Hospital for Children Indianapolis, Indiana | Jodi Skiles, MD - (jskiles@iu.edu) |
| Johns Hopkins Baltimore, Maryland | Allen Chen, MD, PhD - (allenchen@jhmi.edu) |
| Kapiolani Medical Center for Women and Children Honolulu, Hawaii | Randal Wada, MD - (randalw@hawaii.edu) |
| Karmanos Cancer Institute Detroit, Michigan | |
| Levine Children's Hospital Charlotte, North Carolina | Jeffrey Huo, MD - (Jeffrey.Huo@carolinashealthcare.org) Michelle Hyland - (Michelle.Hyland@carolinashealthcare.org) |
| Loma Linda University Cancer Center Loma Linda, California | Hisham Abdel-Azim, MD - (habdelazim@llu.edu) |
| Loyola University Medical Center Maywood, Illinois | Patrick Stiff, MD - (pstiff@lumc.edu) |
| M.D. Anderson Cancer Center Houston, Texas | Elizabeth Shpall, MD - (eshpall@mdanderson.org) |
| Massachusetts General Hospital Boston, Massachusetts | |
| Mayo Clinic - Jacksonville Jacksonville, Florida | Vivek Roy, MD - (roy.vivek@mayo.edu) |
| Mayo Clinic Arizona (adults) Phoenix, Arizona | James Slack, MD - (slack.james@mayo.edu) |
| Mayo Clinic Rochester Rochester, Minnesota | |
| Medical City Dallas Dallas, Texas | Vikas Bhushan, MD - (vikas.bhushan@usoncology.com) |
| Medical College of Georgia Augusta, Georgia | Claude Sportes, MD - (csportes@gru.edu) |
| Medical College of Wisconsin Milwaukee, Wisconsin | Hamadani Mehdi, MD - (mhamadani@mcw.edu) |
| Medical University of South Carolina Charleston, South Carolina | Michelle Hudspeth, MD - (hudspeth@musc.edu) |
| Memorial Sloan-Kettering Cancer Center New York, New York | Ioannis Politikos, MBBS - (politiki@mskcc.org) |
| Methodist Healthcare Blood and Marrow Transplant Center Memphis, Tennessee | Fnu Kaweeta, MD - (fnu.kaweeta@mlh.org) Joshua Boss, RN - (fnu.kaweeta@westclinic.com) |
| Methodist Healthcare System of San Antonio/Texas Transplant Institute San Antonio, Texas | Jose Cruz, MD - (josecarlos.cruz@hcahealthcare.com) |
| Midwestern Regional Medical Center Zion, Illinois | |
| Mount Sinai Medical Center Miami Beach, Florida | Alla Keyzner, MD - (alla.keyzner@mssm.edu) |
| NIH/NCI Bethesda, Maryland | |
| Nationwide Children's Hospital Columbus, Ohio | Rolla Abu-Arja, MD - (rolla.abu-arja@nationwidechildrens.org) |
| Nemours - Alfred I. duPont Hospital for Children Brandywine, Delaware | Emi Caywood, MD - (ecaywood@nemours.org) |
| Nemours Children's Hospital - Mayo Jacksonville Jacksonville, Florida | Michael Joyce, MD - (mjoyce@nemours.org) |
| New York Presbyterian Hospital at Cornell New York, New York | Tsiporah Shore, MD - (tbs2001@med.cornell.edu) |
| New York University Langone Medical Center New York, New York | A. Samer Al-Homsi, MD - (Samer.Al-Homsi@nyumc.org) Kelli Cole - (Kelli.cole@nyumc.org) |
| Nih/Nhlbi Bethesda, Maryland | Richard Childs, MD - (childsr@nih.gov) |
| Nih/Niaid Bethesda, Maryland | Elizabeth Kang, MD - (ekang@niaid.nih.gov) |
| Niklaus Children's Hospital Miami, Florida | Jorge Galvez-Silva, MD - (jorgericardo.galvezsilva@nicklaushealth.org) |
| North Shore University Hospital Manhasset, New York | Ruthee L Bayer, MD - (rbayer@nshs.edu) |
| Northside Hospital Atlanta, Georgia | Scott Solomon, MD - (ssolomon@bmtga.com) |
| Northwestern Memorial Hospital Chicago, Illinois | Kehinde Adekola, MD - (kehinde-adekola@northwestern.edu) |
| Oregon Health & Science University/Doernbecher Children's Hospital Portland, Oregon | Eneida Nemecek, MD - (nemeceke@ohsu.edu) |
| Orlando Health Bone Marrow Transplant and Cellular Therapy Orlando, Florida | Yasser Khaled, MD - (yasser.khaled@orlandohealth.com) |
| Penn State Milton S. Hershey Cancer Center Hershey, Pennsylvania | Shin Mineishi, MD - (smineishi@pennstatehealth.psu.edu) |
| Phoenix Children's Hospital Phoenix, Arizona | |
| Presbyterian St. Luke's/Colorado Blood Cancer Institute Denver, Colorado | Alireza Eghtedar, MD - (alireza.eghtedar@healthonecares.com) |
| Rady Children's Hospital San Diego San Diego, California | Eric Anderson, MD - (eanderson@rchsd.org) |
| Robert Wood Johnson/Cancer Institute of New Jersey New Brunswick, New Jersey | Matthew Matasar, MD, MS - (mm3511@cinj.rutgers.edu) |
| Roger Williams Medical Center Providence, Rhode Island | Todd Roberts, MD - (todd.roberts@chartercare.org) |
| Roswell Park Cancer Institute Buffalo, New York | Philip McCarthy, MD - (philip.mccarthy@roswellpark.org) |
| Rush University Medical Center Chicago, Illinois | |
| Sarah Cannon BMT Program Nashville, Tennessee | |
| Scripps Green Hospital La Jolla, California | Jeffrey W Andrey, MD - (andrey.jeffrey@scrippshealth.org) |
| Southwest Cancer Treatment & Research Center Lubbock, Texas | |
| Spectrum Health Grand Rapids, Michigan | Aly Abdel-Mageed, MD - (aly.mageed@helendevoschildrens.org) |
| St. Jude Childrens Research Hospital Memphis, Tennessee | Renee Madden, MD - (renee.madden@stjude.org) |
| St. Louis University Medical Center St. Louis, Missouri | Sagun Goyal, MD - (sgoyal3@slu.edu) |
| Stanford University Medical Center Palo Alto, California | Andrew Rezvani, MD - (arezvani@stanford.edu) |
| Stony Brook University Hospital Stony Brook, New York | Michael Schuster, MD - (mschuster@notes.cc.sunysb.edu) |
| Strong Memorial Hospital/University of Rochester Rochester, New York | Omar Aljitawi, MD - (omar_aljitawi@urmc.rochester.edu) |
| Sutter Medical Center Sacramento, California | Michael Carroll, MD - (carrolmp@sutterhealth.org) |
| Texas Children's Hospital - Baylor Medical Center Houston, Texas | Robert Krance, MD - (rakrance@txch.org) |
| The Arthur G. James Cancer Hospital/The Ohio State University Medical Center Columbus, Ohio | Sumithira Vasu, MD - (sumithira.vasu@osumc.edu) |
| The Children's Hospital of San Antonio San Antonio, Texas | Martin Andreansky, MD, PhD - (martin.andreansky@bcm.edu) Mark Schambura - (Mark.schambura@christushealth.org) |
| The Jewish Hospital Cincinnati, Ohio | |
| Tufts Medical Center Boston, Massachusetts | Andreas Klein, MD - (aklein2@tuftsmedicalcenter.org) |
| Tulane Medical Center New Orleans, Louisiana | Hana Safa, MD - (hsafah@tulane.edu) |
| UCLA Los Angles, California | Gary Schiller, MD - (gschiller@mednet.ucla.edu) |
| UCSF (adults) San Francisco, California | |
| UCSF (peds) San Francisco, California | |
| Univeristy of Mississippi Medical Center Jackson, Mississippi | Carolyn Bigelow, MD - (cbigelow@umc.edu) |
| University Hospitals Case Medical Center Cleveland, Ohio | Hillard Lazarus, MD - (hillard.lazarus@case.edu) |
| University of Alabama at Birmingham Birmingham, Alabama | Joseph Chewning, MD - (jchewning@peds.uab.edu) |
| University of Arizona Medical Center - Tucson Tucson, Arizona | Emmanuel Katsanis, MD - (katsanis@peds.arizona.edu) |
| University of California San Diego La Jolla, California | Edward Ball, MD - (tball@ucsd.edu) |
| University of Chicago Chicago, Illinois | James LaBelle, MD, PhD - (jlabelle@peds.bsd.uchicago.edu) |
| University of Colorado Hospital Aurora, Colorado | Jonathan Gutman, MD - (jonathan.gutman@ucdenver.edu) |
| University of Florida Shands Medical Center Gainesville, Florida | Jordan Milner, MD - (jordan.milner@ufl.edu) |
| University of Illinois at Chicago Chicago, Illinois | Damiano Rondelli, MD - (drond@uic.edu) |
| University of Iowa Iowa City, Iowa | Margarida Silverman, MD - (margarida-silverman@uiowa.edu) |
| University of Kansas Kansas City, Kansas | Joseph McGuirk, DO - (jmcguirk@kumc.edu) |
| University of Louisville Hospital - James Brown Cancer Center Louisville, Kentucky | William Tse, MD - (w0tse002@louisville.edu) |
| University of Massachusetts Worcester, Massachusetts | Jan Cerny, MD - (Jan.Cerny@umassmemorial.org) |
| University of Miami (adult) Miami, Florida | |
| University of Miami (peds) Miami, Florida | |
| University of Michigan Ann Arbor, Michigan | Jessica Yu - (jjxyu@med.umich.edu) |
| University of Nebraska Medical Center Omaha, Nebraska | Phyllis Warkenton, MD - (pwarkent@unmc.edu) |
| University of North Carolina at Chapel Hill Chapel Hill, North Carolina | |
| University of Oklahoma Health Science Center Oklahoma City, Oklahoma | Adam Asch, MD - (adam-asch@ouhsc.edu) |
| University of Pennsylvania/Thomas Jefferson Pittsburg, Pennsylvania | Elizabeth Hexner, MD - (elizabeth.hexner@uphs.upenn.edu) |
| University of Pittsburgh Medical Center Pittsburgh, Pennsylvania | Alison Sehgal, MD - (sehgalar@upmc.edu) |
| University of Texas Southwestern Medical Center Dallas, Texas | |
| University of Utah Salt Lake City, Utah | Ahmad Rayes, MD - (ahmad.rayes@hsc.utah.edu) |
| University of Virginia Charlottesville, Virginia | Karen Ballen, MD - (KB3TC@hscmail.mcc.virginia.edu) |
| University of Wisconsin - Madison Madison, Wisconsin | Kenneth DeSantes, MD - (kbdesantes@pediatrics.wisc.edu) |
| VA Puget Sound HCS Seattle, Washington | |
| VA Tennessee Valley Healthcare System Nashville, Tennessee | |
| Vanderbilt University Nashville, Tennessee | Michael Byrne, MD - (michael.byrne@vumc.org) |
| Virginia Commonwealth University Richmond, Virginia | John McCarty, MD - (jmccarty@vcu.edu) |
| Wake Forest University Winston-Salem, North Carolina | |
| Washington University St. Louis St Louis, Missouri | Geoffrey Uy, MD - (guy@wustl.edu) |
| Washington University/St. Louis Children's Hospital St Louis, Missouri | Geoffrey Uy, MD - (guy@wustl.edu) |
| West Virginia University Morgantown, West Virginia | Lauren Veltri, MD - (lveltri@hsc.wvu.edu) |
| Westchester Medical Center Valhalla, New York | Mitchell Cairo, MD - (mitchell_cairo@nymc.edu) |
| Western Penn Hospital Pittsburg, Pennsylvania | John Lister, MD - (Jlister@wpahs.org) |
| Yale New Haven Hospital New Haven, Connecticut | Aaron Flagg, MD - (aron.flagg@yale.edu) |
| Zachary & Elizabeth Fisher Bone Marrow Transplant Program (Brooke Army Medical Center) Fort Sam Houston, Texas | Bradley Beeler, MD - (bradley.w.beeler.mil@health.mil) |
Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS) (MAAIS)
Lisa Datta, MS - ibd@jhu.edu
Kuemmerle, John, F
N/A
NCT01169194
HM12998
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
• African Americans with a confirmed diagnosis of Inflammatory Bowel Disease (IBD)
• African Americans without a diagnosis of IBD and without a family history of IBD for comparison purposes
Exclusion Criteria:
Patients whose IBD cannot be confirmed
Inflammatory Bowel Disease
Inflammatory Bowel Disease, Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis, IBD, CD, UC, IC, African American IBD, African American CD, African American UC, African American IC, Black IBD, Black CD, Black UC, Black IC, African American Inflammatory Bowel Disease, African American Crohn's Disease, African American Ulcerative Colitis, African American Indeterminate Colitis, Black Inflammatory Bowel Disease, Black Crohn's Disease, Black Ulcerative Colitis, Black Indeterminate Colitis
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 10 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Baylor College of Medicine Houston, Texas | Jullia Guardado - (jguardad@bcm.edu) |
| Johns Hopkins University School Of Medicine Baltimore, Maryland | Lisa Datta, MS - (ibd@jhu.edu) |
| Robert Wood Johnson Medical School New Brunswick, New Jersey | - (IBD_genetics@rwjms.rutgers.edu) |
| University of Alabama at Birmingham Birmingham, Alabama | Angelia Johnson - (angeliagjohnson@uabmc.edu) |
| University of Chicago Chicago, Illinois | Kristi Kearney, RN - (kkearney@medicine.bsd.uchicago.edu) |
| University of Louisville Louisville, Kentucky | Susie Mann, LPN - (suzanne.mann@louisville.edu) |
| University of Maryland Baltimore/University of Maryland Medical System Baltimore, Maryland | Elaine Puppa, RN - (eleonard@peds.umaryland.edu) |
| University of North Carolina Chapel Hill Chapel Hill, North Carolina | Susan Jackson, MPA - (Susan_jackson@med.unc.edu) |
| Virginia Commonwealth University Richmond, Virginia | Jay Kuemmerle - (john.kuemmerle@vcuhealth.org) |
| Weill Cornell Medical College New York, New York | Fatiha Chabouni - (fac2005@med.cornell.edu) |
Project: Every Child for Younger Patients With Cancer (EVERYCHILD)
Gwaltney, Lindsey - lbgwaltney@vcu.edu
Massey, Gita, V.
N/A
NCT02402244
HM20006485
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* Enrollment must occur within 6 months of initial disease presentation OR within 6 months of refractory disease, disease progression, disease recurrence, second or secondary malignancy, or post-mortem
* Patients previously enrolled on ACCRN07 are eligible to enroll on Tracking Outcome, Registry and Future Contact components of APEC14B1 any time after they reach age of majority
* Patients with a known or suspected neoplasm that occurs in the pediatric, adolescent or young adult populations are eligible for enrollment as follows:
* All cancer cases with an International Classification of Diseases for Oncology (ICD-O) histologic behavior code of one "1" (borderline), two "2" (carcinoma in situ) or three "3" (malignant)
* All neoplastic lesions of the central nervous system regardless of behavior, i.e., benign, borderline or malignant
* All neoplastic lesions of the kidney regardless of behavior, i.e., benign, borderline or malignant
* The following other benign/borderline conditions:
* Mesoblastic nephroma
* Teratomas (mature and immature types)
* Myeloproliferative diseases including transient myeloproliferative disease
* Langerhans cell histiocytosis
* Lymphoproliferative diseases
* Desmoid tumors
* Gonadal stromal cell tumors
* Neuroendocrine tumors including pheochromocytoma
* Melanocytic tumors, except clearly benign nevi
* Ganglioneuromas
* Subjects must be =\< 25 years of age at time of original diagnosis, except for patients who are being screened specifically for eligibility onto a COG (or COG participating National Clinical Trials Network \[NCTN\]) therapeutic study, for which there is a higher upper age limit
* All patients or their parents or legally authorized representatives must sign a written informed consent and agree to participate in at least one component of the study; parents will be asked to sign a separate consent for their own biospecimen submission
* If patients or their parents or legally authorized representatives have not signed the Part A subject consent form at the time of a diagnostic bone marrow procedure, it is recommended that they initially provide consent for drawing extra bone marrow using the Consent for Collection of Additional Bone Marrow; consent using the Part A subject consent form must be provided prior to any other procedures for eligibility screening or banking under APEC14B1 OTHER: Cytology Specimen Collection Procedure, OTHER: Medical Chart Review
Adrenal Gland Pheochromocytoma, Carcinoma In Situ, Central Nervous System Neoplasm, Childhood Immature Teratoma, Childhood Kidney Neoplasm, Childhood Langerhans Cell Histiocytosis, Childhood Mature Teratoma, Congenital Mesoblastic Nephroma, Desmoid Fibromatosis, Ganglioneuroma, Lymphoproliferative Disorder, Malignant Neoplasm, Malignant Solid Neoplasm, Melanocytic Neoplasm, Myeloproliferative Neoplasm, Neoplasm of Uncertain Malignant Potential, Neuroendocrine Neoplasm, Stromal Neoplasm
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 242 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| AdventHealth Orlando Orlando, Florida | Site Public Contact - (FH.Cancer.Research@flhosp.org) |
| Advocate Children's Hospital-Oak Lawn Oak Lawn, Illinois | |
| Advocate Children's Hospital-Park Ridge Park Ridge, Illinois | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Albany Medical Center Albany, New York | |
| Alberta Children's Hospital Calgary, Alberta | Site Public Contact - (research4kids@ucalgary.ca) |
| Alfred I duPont Hospital for Children Wilmington, Delaware | Site Public Contact - (Allison.bruce@nemours.org) |
| Alliance for Childhood Diseases/Cure 4 the Kids Foundation Las Vegas, Nevada | Site Public Contact - (research@sncrf.org) |
| Arkansas Children's Hospital Little Rock, Arkansas | |
| Arnold Palmer Hospital for Children Orlando, Florida | Site Public Contact - (Jennifer.spinelli@orlandohealth.com) |
| Ascension Saint Vincent Indianapolis Hospital Indianapolis, Indiana | Site Public Contact - (research@stvincent.org) |
| Atrium Health Navicent Macon, Georgia | Site Public Contact - (andrew.weatherall@atriumhealth.org) |
| Augusta University Medical Center Augusta, Georgia | Site Public Contact - (ga_cares@augusta.edu) |
| BI-LO Charities Children's Cancer Center Greenville, South Carolina | |
| Banner Children's at Desert Mesa, Arizona | |
| Banner University Medical Center - Tucson Tucson, Arizona | Site Public Contact - (UACC-IIT@uacc.arizona.edu) |
| Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center Houston, Texas | Site Public Contact - (burton@bcm.edu) |
| Baystate Medical Center Springfield, Massachusetts | Site Public Contact - (tamara.wrenn@baystatehealth.org) |
| Blank Children's Hospital Des Moines, Iowa | Site Public Contact - (samantha.mallory@unitypoint.org) |
| British Columbia Children's Hospital Vancouver, British Columbia | |
| Bronson Methodist Hospital Kalamazoo, Michigan | Site Public Contact - (crcwm-regulatory@crcwm.org) |
| Brooke Army Medical Center Fort Sam Houston, Texas | |
| Broward Health Medical Center Fort Lauderdale, Florida | Site Public Contact - (Allison.bruce@nemours.org) |
| C S Mott Children's Hospital Ann Arbor, Michigan | |
| CHU de Quebec-Centre Hospitalier de l'Universite Laval (CHUL) Québec, | Site Public Contact - (rechclinique@crchudequebec.ulaval.ca) |
| CancerCare Manitoba Winnipeg, Manitoba | Site Public Contact - (ctu_web@cancercare.mb.ca) |
| Cardinal Glennon Children's Medical Center St Louis, Missouri | |
| Carilion Children's Roanoke, Virginia | Site Public Contact - (wpmccarty@carilionclinic.org) |
| Carolinas Medical Center/Levine Cancer Institute Charlotte, North Carolina | |
| Cedars Sinai Medical Center Los Angeles, California | |
| Centre Hospitalier Universitaire Sainte-Justine Montreal, Quebec | Site Public Contact - (yvan.samson@umontreal.ca) |
| Centre Hospitalier Universitaire de Sherbrooke-Fleurimont Sherbrooke, Quebec | Site Public Contact - (crcinformation.chus@ssss.gouv.qc.ca) |
| Children's Healthcare of Atlanta - Arthur M Blank Hospital Atlanta, Georgia | Site Public Contact - (Olivia.Floyd@choa.org) |
| Children's Hospital London, Ontario | |
| Children's Hospital Colorado Aurora, Colorado | Site Public Contact - (josh.b.gordon@nsmtp.kp.org) |
| Children's Hospital Los Angeles Los Angeles, California | |
| Children's Hospital Medical Center Of Akron Akron, Ohio | |
| Children's Hospital New Orleans New Orleans, Louisiana | Site Public Contact - (CHResearch@lcmchealth.org) |
| Children's Hospital Of Eastern Ontario Ottawa, Ontario | |
| Children's Hospital and Medical Center of Omaha Omaha, Nebraska | |
| Children's Hospital of Alabama Birmingham, Alabama | Site Public Contact - (oncologyresearch@peds.uab.edu) |
| Children's Hospital of Michigan Detroit, Michigan | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Children's Hospital of Orange County Orange, California | Site Public Contact - (oncresearch@choc.org) |
| Children's Hospital of Philadelphia Philadelphia, Pennsylvania | Site Public Contact - (CancerTrials@email.chop.edu) |
| Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania | Site Public Contact - (jean.tersak@chp.edu) |
| Children's Hospital of San Antonio San Antonio, Texas | Site Public Contact - (bridget.medina@christushealth.org) |
| Children's Hospital of Wisconsin Milwaukee, Wisconsin | Site Public Contact - (MACCCTO@mcw.edu) |
| Children's Hospital of the King's Daughters Norfolk, Virginia | Site Public Contact - (CCBDCresearch@chkd.org) |
| Children's Hospitals and Clinics of Minnesota - Minneapolis Minneapolis, Minnesota | Site Public Contact - (pauline.mitby@childrensmn.org) |
| Children's Mercy Hospitals and Clinics Kansas City, Missouri | Site Public Contact - (rryan@cmh.edu) |
| Children's National Medical Center Washington D.C., District of Columbia | Site Public Contact - (OncCRC_OnCall@childrensnational.org) |
| Christchurch Hospital Christchurch, | |
| Cincinnati Children's Hospital Medical Center Cincinnati, Ohio | Site Public Contact - (cancer@cchmc.org) |
| City of Hope Comprehensive Cancer Center Duarte, California | Site Public Contact - (becomingapatient@coh.org) |
| Cleveland Clinic Foundation Cleveland, Ohio | Site Public Contact - (TaussigResearch@ccf.org) |
| Connecticut Children's Medical Center Hartford, Connecticut | |
| Cook Children's Medical Center Fort Worth, Texas | Site Public Contact - (CookChildrensResearch@cookchildrens.org) |
| Corewell Health Children's Royal Oak, Michigan | |
| Corewell Health Grand Rapids Hospitals - Butterworth Hospital Grand Rapids, Michigan | |
| Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital Grand Rapids, Michigan | Site Public Contact - (crcwm-regulatory@crcwm.org) |
| Covenant Children's Hospital Lubbock, Texas | Site Public Contact - (mbisbee@providence.org) |
| Dana-Farber Cancer Institute Boston, Massachusetts | |
| Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center Lebanon, New Hampshire | Site Public Contact - (cancer.research.nurse@dartmouth.edu) |
| Dayton Children's Hospital Dayton, Ohio | |
| Dell Children's Medical Center of Central Texas Austin, Texas | Site Public Contact - (TXAUS-DL-SFCHemonc.research@ascension.org) |
| Driscoll Children's Hospital Corpus Christi, Texas | Site Public Contact - (Crystal.DeLosSantos@dchstx.org) |
| Duke University Medical Center Durham, North Carolina | |
| East Carolina University Greenville, North Carolina | Site Public Contact - (eubankss@ecu.edu) |
| East Tennessee Childrens Hospital Knoxville, Tennessee | |
| Eastern Maine Medical Center Bangor, Maine | |
| Edwards Comprehensive Cancer Center Huntington, West Virginia | Site Public Contact - (Christina.Cole@chhi.org) |
| El Paso Children's Hospital El Paso, Texas | Site Public Contact - (ranjan.bista@ttuhsc.edu) |
| Geisinger Medical Center Danville, Pennsylvania | Site Public Contact - (HemonCCTrials@geisinger.edu) |
| Golisano Children's Hospital of Southwest Florida Fort Myers, Florida | Site Public Contact - (molly.arnstrom@leehealth.org) |
| HIMA San Pablo Oncologic Hospital Caguas, | |
| Hackensack University Medical Center Hackensack, New Jersey | |
| Henry Ford Health Saint John Hospital Detroit, Michigan | |
| Hospital for Sick Children Toronto, Ontario | Site Public Contact - (ask.CRS@sickkids.ca) |
| Hurley Medical Center Flint, Michigan | |
| IWK Health Centre Halifax, Nova Scotia | Site Public Contact - (Research@iwk.nshealth.ca) |
| Inova Fairfax Hospital Falls Church, Virginia | |
| Janeway Child Health Centre St. John's, Newfoundland and Labrador | Site Public Contact - (beverlyj.mitchell@easternhealth.ca) |
| Jersey Shore Medical Center Neptune City, New Jersey | |
| Jim Pattison Children's Hospital Saskatoon, Saskatchewan | Site Public Contact - (Jessica.Marien@saskhealthauthority.ca) |
| John Hunter Children's Hospital Hunter Regional Mail Centre, New South Wales | |
| Johns Hopkins All Children's Hospital St. Petersburg, Florida | Site Public Contact - (Ashley.Repp@jhmi.edu) |
| Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland | Site Public Contact - (jhcccro@jhmi.edu) |
| Kaiser Permanente Downey Medical Center Downey, California | |
| Kaiser Permanente-Oakland Oakland, California | Site Public Contact - (Kpoct@kp.org) |
| Kapiolani Medical Center for Women and Children Honolulu, Hawaii | |
| King Faisal Specialist Hospital and Research Centre Riyadh, | |
| Kingston Health Sciences Centre Kingston, Ontario | Site Public Contact - (cc-clinicaltrials@kgh.kari.net) |
| Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, New York | Site Public Contact - (CancerTrials@nyulangone.org) |
| Legacy Emanuel Children's Hospital Portland, Oregon | |
| Lehigh Valley Hospital - Muhlenberg Bethlehem, Pennsylvania | |
| Lehigh Valley Hospital-Cedar Crest Allentown, Pennsylvania | Site Public Contact - (Morgan_M.Horton@lvhn.org) |
| Loma Linda University Medical Center Loma Linda, California | |
| Loyola University Medical Center Maywood, Illinois | |
| Lucile Packard Children's Hospital Stanford University Palo Alto, California | Site Public Contact - (ccto-office@stanford.edu) |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Torrance, California | |
| Lurie Children's Hospital-Chicago Chicago, Illinois | |
| M D Anderson Cancer Center Houston, Texas | Site Public Contact - (askmdanderson@mdanderson.org) |
| Madigan Army Medical Center Tacoma, Washington | Site Public Contact - (melissa.a.forouhar.mil@health.mil) |
| Maimonides Medical Center Brooklyn, New York | |
| Maine Children's Cancer Program Scarborough, Maine | Site Public Contact - (sverwys@mmc.org) |
| Marshfield Medical Center-Marshfield Marshfield, Wisconsin | Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org) |
| Mary Bridge Children's Hospital and Health Center Tacoma, Washington | Site Public Contact - (research@multicare.org) |
| Massachusetts General Hospital Cancer Center Boston, Massachusetts | |
| Mattel Children's Hospital UCLA Los Angeles, California | |
| Mayo Clinic in Rochester Rochester, Minnesota | |
| McMaster Children's Hospital at Hamilton Health Sciences Hamilton, Ontario | |
| MedStar Georgetown University Hospital Washington D.C., District of Columbia | |
| Medical City Dallas Hospital Dallas, Texas | |
| Medical University of South Carolina Charleston, South Carolina | Site Public Contact - (hcc-clinical-trials@musc.edu) |
| Memorial Health University Medical Center Savannah, Georgia | Site Public Contact - (Lorraine.OHara@hcahealthcare.com) |
| Memorial Regional Hospital/Joe DiMaggio Children's Hospital Hollywood, Florida | Site Public Contact - (OHR@mhs.net) |
| Memorial Sloan Kettering Cancer Center New York, New York | |
| Mercy Hospital Saint Louis St Louis, Missouri | |
| Methodist Children's Hospital of South Texas San Antonio, Texas | Site Public Contact - (Vinod.GidvaniDiaz@hcahealthcare.com) |
| Miami Cancer Institute Miami, Florida | |
| Michigan State University East Lansing, Michigan | |
| Miller Children's and Women's Hospital Long Beach Long Beach, California | |
| Mission Hospital Asheville, North Carolina | Site Public Contact - (NCDV.ResearchRegulatory@HCAHealthcare.com) |
| Monash Medical Center-Clayton Campus Clayton, Victoria | |
| Montefiore Medical Center - Moses Campus The Bronx, New York | Site Public Contact - (eskwak@montefiore.org) |
| Morristown Medical Center Morristown, New Jersey | |
| Mount Sinai Hospital New York, New York | Site Public Contact - (CCTO@mssm.edu) |
| NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, New York | Site Public Contact - (nr2616@cumc.columbia.edu) |
| NYP/Weill Cornell Medical Center New York, New York | |
| NYU Langone Hospital - Long Island Mineola, New York | Site Public Contact - (cancertrials@nyulangone.org) |
| Natalie Warren Bryant Cancer Center at Saint Francis Tulsa, Oklahoma | |
| Nationwide Children's Hospital Columbus, Ohio | Site Public Contact - (Melinda.Triplet@nationwidechildrens.org) |
| Naval Medical Center - Portsmouth Portsmouth, Virginia | |
| Naval Medical Center -San Diego San Diego, California | |
| Nemours Children's Clinic - Pensacola Pensacola, Florida | |
| Nemours Children's Clinic-Jacksonville Jacksonville, Florida | Site Public Contact - (Allison.bruce@nemours.org) |
| Nemours Children's Hospital Orlando, Florida | Site Public Contact - (Allison.bruce@nemours.org) |
| New York Medical College Valhalla, New York | |
| Newark Beth Israel Medical Center Newark, New Jersey | Site Public Contact - (Christine.Kosmides@rwjbh.org) |
| Nicklaus Children's Hospital Miami, Florida | |
| Northwestern Medicine Central DuPage Hospital Winfield, Illinois | Site Public Contact - (Claudine.Gamster@CadenceHealth.org) |
| Norton Children's Hospital Louisville, Kentucky | Site Public Contact - (CancerResource@nortonhealthcare.org) |
| Novant Health Presbyterian Medical Center Charlotte, North Carolina | Site Public Contact - (kashah@novanthealth.org) |
| Ochsner Medical Center Jefferson New Orleans, Louisiana | Site Public Contact - (Elisemarie.curry@ochsner.org) |
| Oregon Health and Science University Portland, Oregon | Site Public Contact - (trials@ohsu.edu) |
| Palms West Radiation Therapy Loxahatchee Groves, Florida | |
| Penn State Children's Hospital Hershey, Pennsylvania | |
| Perth Children's Hospital Perth, Western Australia | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Phoenix Childrens Hospital Phoenix, Arizona | |
| Presbyterian Hospital Albuquerque, New Mexico | Site Public Contact - (wburman@phs.org) |
| Primary Children's Hospital Salt Lake City, Utah | |
| Princess Margaret Hospital for Children Perth, Western Australia | |
| Prisma Health Richland Hospital Columbia, South Carolina | |
| ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital Toledo, Ohio | Site Public Contact - (PCIOncResearch@promedica.org) |
| Providence Alaska Medical Center Anchorage, Alaska | Site Public Contact - (AKPAMC.OncologyResearchSupport@providence.org) |
| Providence Sacred Heart Medical Center and Children's Hospital Spokane, Washington | Site Public Contact - (HopeBeginsHere@providence.org) |
| Queensland Children's Hospital South Brisbane, Queensland | |
| Rady Children's Hospital - San Diego San Diego, California | |
| Rainbow Babies and Childrens Hospital Cleveland, Ohio | |
| Renown Regional Medical Center Reno, Nevada | Site Public Contact - (research@sncrf.org) |
| Rhode Island Hospital Providence, Rhode Island | |
| Riley Hospital for Children Indianapolis, Indiana | |
| Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center Denver, Colorado | |
| Roswell Park Cancer Institute Buffalo, New York | Site Public Contact - (askroswell@roswellpark.org) |
| Royal Children's Hospital Parkville, Victoria | Site Public Contact - (Jordan.Hansford@rch.org.au) |
| Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital New Brunswick, New Jersey | |
| Sacred Heart Hospital Pensacola, Florida | Site Public Contact - (eebrou@ascension.org) |
| Saint Christopher's Hospital for Children Philadelphia, Pennsylvania | |
| Saint Joseph's Hospital/Children's Hospital-Tampa Tampa, Florida | Site Public Contact - (jennifer.manns@baycare.org) |
| Saint Joseph's Regional Medical Center Paterson, New Jersey | Site Public Contact - (HallL@sjhmc.org) |
| Saint Jude Children's Research Hospital Memphis, Tennessee | Site Public Contact - (referralinfo@stjude.org) |
| Saint Jude Midwest Affiliate Peoria, Illinois | |
| Saint Luke's Cancer Institute - Boise Boise, Idaho | Site Public Contact - (eslinget@slhs.org) |
| Saint Mary's Medical Center West Palm Beach, Florida | |
| Saint Peter's University Hospital New Brunswick, New Jersey | Site Public Contact - (kcovert@saintpetersuh.com) |
| Saint Vincent Hospital Cancer Center Green Bay Green Bay, Wisconsin | Site Public Contact - (ewd_research_admin@hshs.org) |
| San Jorge Children's Hospital San Juan, | |
| Sanford Broadway Medical Center Fargo, North Dakota | Site Public Contact - (OncologyClinicalTrialsFargo@sanfordhealth.org) |
| Sanford USD Medical Center - Sioux Falls Sioux Falls, South Dakota | Site Public Contact - (OncologyClinicalTrialsSF@SanfordHealth.org) |
| Santa Barbara Cottage Hospital Santa Barbara, California | |
| Saskatoon Cancer Centre Saskatoon, Saskatchewan | |
| Scott and White Memorial Hospital Temple, Texas | |
| Seattle Children's Hospital Seattle, Washington | |
| Sinai Hospital of Baltimore Baltimore, Maryland | Site Public Contact - (pridgely@lifebridgehealth.org) |
| Southern Illinois University School of Medicine Springfield, Illinois | |
| Starship Children's Hospital Grafton, Auckland | |
| State University of New York Upstate Medical University Syracuse, New York | |
| Stony Brook University Medical Center Stony Brook, New York | |
| Summerlin Hospital Medical Center Las Vegas, Nevada | Site Public Contact - (research@sncrf.org) |
| Sunrise Hospital and Medical Center Las Vegas, Nevada | Site Public Contact - (research@sncrf.org) |
| Sutter Medical Center Sacramento Sacramento, California | Site Public Contact - (NCIclinicaltrials@sutterhealth.org) |
| Sydney Children's Hospital Randwick, New South Wales | |
| T C Thompson Children's Hospital Chattanooga, Tennessee | |
| Tampa General Hospital Tampa, Florida | Site Public Contact - (syapchanyk@tgh.org) |
| Texas Tech University Health Sciences Center-Amarillo Amarillo, Texas | |
| The Children's Hospital at TriStar Centennial Nashville, Tennessee | |
| The Children's Hospital at Westmead Westmead, New South Wales | |
| The Montreal Children's Hospital of the MUHC Montreal, Quebec | Site Public Contact - (info@thechildren.com) |
| The Steven and Alexandra Cohen Children's Medical Center of New York New Hyde Park, New York | |
| Tripler Army Medical Center Honolulu, Hawaii | |
| Tufts Children's Hospital Boston, Massachusetts | |
| UCSF Benioff Children's Hospital Oakland Oakland, California | Site Public Contact - (Carla.Golden@ucsf.edu) |
| UCSF Medical Center-Mission Bay San Francisco, California | Site Public Contact - (cancertrials@ucsf.edu) |
| UMC Cancer Center / UMC Health System Lubbock, Texas | |
| UMass Memorial Medical Center - University Campus Worcester, Massachusetts | Site Public Contact - (cancer.research@umassmed.edu) |
| UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina | Site Public Contact - (cancerclinicaltrials@med.unc.edu) |
| USA Health Strada Patient Care Center Mobile, Alabama | |
| UT Southwestern/Simmons Cancer Center-Dallas Dallas, Texas | Site Public Contact - (canceranswerline@UTSouthwestern.edu) |
| University Medical Center of Southern Nevada Las Vegas, Nevada | Site Public Contact - (research@sncrf.org) |
| University Pediatric Hospital San Juan, | |
| University of Alberta Hospital Edmonton, Alberta | Site Public Contact - (pedsoncologyresearch@ahs.ca) |
| University of California Davis Comprehensive Cancer Center Sacramento, California | |
| University of Chicago Comprehensive Cancer Center Chicago, Illinois | Site Public Contact - (cancerclinicaltrials@bsd.uchicago.edu) |
| University of Florida Health Science Center - Gainesville Gainesville, Florida | Site Public Contact - (cancer-center@ufl.edu) |
| University of Illinois Chicago, Illinois | |
| University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa | |
| University of Kentucky/Markey Cancer Center Lexington, Kentucky | |
| University of Maryland/Greenebaum Cancer Center Baltimore, Maryland | |
| University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida | |
| University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota | |
| University of Mississippi Medical Center Jackson, Mississippi | |
| University of Missouri Children's Hospital Columbia, Missouri | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| University of Nebraska Medical Center Omaha, Nebraska | Site Public Contact - (unmcrsa@unmc.edu) |
| University of New Mexico Cancer Center Albuquerque, New Mexico | Site Public Contact - (HSC-ClinicalTrialInfo@salud.unm.edu) |
| University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma | Site Public Contact - (ou-clinical-trials@ouhsc.edu) |
| University of Rochester Rochester, New York | |
| University of Texas Health Science Center at San Antonio San Antonio, Texas | Site Public Contact - (phoresearchoffice@uthscsa.edu) |
| University of Vermont and State Agricultural College Burlington, Vermont | Site Public Contact - (rpo@uvm.edu) |
| University of Virginia Cancer Center Charlottesville, Virginia | Site Public Contact - (uvacancertrials@hscmail.mcc.virginia.edu) |
| University of Wisconsin Carbone Cancer Center - University Hospital Madison, Wisconsin | |
| VCU Massey Comprehensive Cancer Center Richmond, Virginia | Site Public Contact - (CTOclinops@vcu.edu) |
| Valley Children's Hospital Madera, California | Site Public Contact - (Research@valleychildrens.org) |
| Vanderbilt University/Ingram Cancer Center Nashville, Tennessee | |
| Vannie Cook Children's Clinic McAllen, Texas | Site Public Contact - (jrhartl1@txch.org) |
| Wake Forest University Health Sciences Winston-Salem, North Carolina | |
| Walter Reed National Military Medical Center Bethesda, Maryland | |
| Washington University School of Medicine St Louis, Missouri | Site Public Contact - (info@siteman.wustl.edu) |
| Wayne State University/Karmanos Cancer Institute Detroit, Michigan | |
| West Michigan Cancer Center Kalamazoo, Michigan | |
| West Virginia University Charleston Division Charleston, West Virginia | |
| West Virginia University Healthcare Morgantown, West Virginia | Site Public Contact - (cancertrialsinfo@hsc.wvu.edu) |
| Women's and Children's Hospital-Adelaide North Adelaide, South Australia | Site Public Contact - (cywhs.oncsec@health.sa.gov.au) |
| Yale University New Haven, Connecticut | Site Public Contact - (canceranswers@yale.edu) |
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Gwaltney, Lindsey - lbgwaltney@vcu.edu
Massey, Gita, V.
N/A
NCT00904241
HM1538
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* All newly diagnosed patients with suspected neuroblastoma, suspected ganglioneuroblastoma, or suspected ganglioneuroma/maturing subtype seen at Children's Oncology Group (COG) institutions are eligible for this study
* There will be no penalty under any circumstances for enrollment of a patient whose definitive institutional diagnosis, or central review diagnosis, is found to be a tumor other than neuroblastoma, ganglioneuroblastoma, or ganglioneuroma/ maturing subtype
* Patients may not have received chemotherapy prior to enrollment on ANBL00B1 and procurement of study-related tissues with the following exception:
* Patients that in the opinion of the treating physician are too ill to undergo pre-treatment tissue biopsy and require EMERGENT chemotherapy may be enrolled on ANBL00B1; documentation of the emergent nature of therapy initiation is required
* It is required that a good faith effort (documented by specimen tracking) be made to submit a neuroblastoma sample (tumor, metastasis, and/or tumor-involved bone marrow) of sufficient quality for MYCN analysis in the Neuroblastoma Reference Laboratory in order for any newly diagnosed patient to be enrolled on ANBL00B1; this should be obtained prior to initiation of therapy
* Exceptions
* In rare cases, patients may be deemed too ill to undergo pre-treatment tissue biopsy and require EMERGENT therapy; the following eligibility guidelines apply to these cases:
* For presumed INSS stage 4S patients: Efforts to submit tumor tissue (e.g., primary tumor, skin nodule, or metastatic site) within 96 hours of EMERGENT therapy initiation should be made; however, if the child is deemed too unstable for such a procedure they may still be enrolled as long as pre-treatment peripheral blood and serum have been submitted
* For all other INSS stages: tumor tissue should be obtained as soon as possible within 96 hours of EMERGENT therapy initiation; patients without tumor tissues submitted within this time-frame are not eligible for enrollment
* Note: it may not be possible to obtain all necessary tumor biomarkers for therapy stratification in such cases; if a patient enrolled on ANBL00B1 undergoes an additional diagnostic procedure within 96 hours of initiating therapy, additional tumor specimens may be submitted to obtain biomarkers used for risk classification; the decision to perform such procedures, and/or submit these specimens, is to be made by the managing clinicians and should reflect the clinical need to know the status of such biomarkers
* Patients enrolled on ANBL1232 in Group A (either A1 or A2) will not have a tumor biopsy or resection upfront; tumor tissue submission is therefore not required for these patients to enroll on ANBL00B1; a peripheral blood and serum sample is the only specimen required to be submitted for this group of patients; should they undergo a biopsy or resection at a later date tumor can be submitted for biomarker testing at this time
* All patients and/or their parents or legal guardians must sign a written informed consent
* All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met
Exclusion Criteria:
* Patients with relapsed neuroblastoma who were not enrolled on ANBL00B1 at original diagnosis are NOT eligible; samples should be submitted as part of the ABTR04B1 protocol OTHER: Cytology Specimen Collection Procedure, OTHER: Laboratory Biomarker Analysis
Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 259 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Advocate Children's Hospital-Oak Lawn Oak Lawn, Illinois | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Advocate Children's Hospital-Park Ridge Park Ridge, Illinois | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Advocate Lutheran General Hospital Park Ridge, Illinois | |
| Albany Medical Center Albany, New York | |
| Alberta Children's Hospital Calgary, Alberta | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Alfred I duPont Hospital for Children Wilmington, Delaware | Site Public Contact - (dperry@nemours.org) |
| Allan Blair Cancer Centre Regina, Saskatchewan | |
| Alliance for Childhood Diseases/Cure 4 the Kids Foundation Las Vegas, Nevada | Site Public Contact - (research@sncrf.org) |
| Arkansas Children's Hospital Little Rock, Arkansas | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Arnold Palmer Hospital for Children Orlando, Florida | Site Public Contact - (melissa.leffin@orlandohealth.com) |
| Ascension Saint John Hospital Detroit, Michigan | Site Public Contact - (stephanie.couch@stjoeshealth.org) |
| Augusta University Medical Center Augusta, Georgia | Site Public Contact - (ga_cares@augusta.edu) |
| BI-LO Charities Children's Cancer Center Greenville, South Carolina | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center Houston, Texas | Site Public Contact - (burton@bcm.edu) |
| Baystate Medical Center Springfield, Massachusetts | Site Public Contact - (tamara.wrenn@baystatehealth.org) |
| Beaumont Children's Hospital-Royal Oak Royal Oak, Michigan | |
| Blank Children's Hospital Des Moines, Iowa | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| British Columbia Children's Hospital Vancouver, British Columbia | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Bronson Methodist Hospital Kalamazoo, Michigan | Site Public Contact - (crcwm-regulatory@crcwm.org) |
| Brooke Army Medical Center Fort Sam Houston, Texas | |
| Brooklyn Hospital Center Brooklyn, New York | |
| Broward Health Medical Center Fort Lauderdale, Florida | |
| C S Mott Children's Hospital Ann Arbor, Michigan | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| CancerCare Manitoba Winnipeg, Manitoba | Site Public Contact - (ctu_web@cancercare.mb.ca) |
| Cardinal Glennon Children's Medical Center St Louis, Missouri | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Cardon Children's Medical Center Mesa, Arizona | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Carilion Clinic Children's Hospital Roanoke, Virginia | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Carolinas Medical Center/Levine Cancer Institute Charlotte, North Carolina | |
| Cedars Sinai Medical Center Los Angeles, California | |
| Centre Hospitalier Universitaire Sainte-Justine Montreal, Quebec | |
| Centre Hospitalier Universitaire de Quebec Québec, | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Children's Healthcare of Atlanta - Egleston Atlanta, Georgia | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Children's Hospital London, Ontario | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Children's Hospital Colorado Aurora, Colorado | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Children's Hospital Los Angeles Los Angeles, California | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Children's Hospital Medical Center Of Akron Akron, Ohio | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Children's Hospital New Orleans New Orleans, Louisiana | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Children's Hospital Of Eastern Ontario Ottawa, Ontario | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Children's Hospital and Medical Center of Omaha Omaha, Nebraska | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Children's Hospital and Research Center at Oakland Oakland, California | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Children's Hospital of Alabama Birmingham, Alabama | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Children's Hospital of Orange County Orange, California | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Children's Hospital of Philadelphia Philadelphia, Pennsylvania | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Children's Hospital of San Antonio San Antonio, Texas | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Children's Hospital of Wisconsin Milwaukee, Wisconsin | Site Public Contact - (MACCCTO@mcw.edu) |
| Children's Hospital of the King's Daughters Norfolk, Virginia | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Children's Hospitals and Clinics of Minnesota - Minneapolis Minneapolis, Minnesota | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Children's Mercy Hospitals and Clinics Kansas City, Missouri | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Children's National Medical Center Washington D.C., District of Columbia | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Christchurch Hospital Christchurch, | |
| Cincinnati Children's Hospital Medical Center Cincinnati, Ohio | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| City of Hope Comprehensive Cancer Center Duarte, California | Site Public Contact - (becomingapatient@coh.org) |
| Cleveland Clinic Foundation Cleveland, Ohio | |
| Columbia Regional Columbia, Missouri | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Connecticut Children's Medical Center Hartford, Connecticut | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Cook Children's Medical Center Fort Worth, Texas | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Covenant Children's Hospital Lubbock, Texas | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Dana-Farber Cancer Institute Boston, Massachusetts | |
| Dartmouth Hitchcock Medical Center Lebanon, New Hampshire | |
| Dayton Children's Hospital Dayton, Ohio | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Dell Children's Medical Center of Central Texas Austin, Texas | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Driscoll Children's Hospital Corpus Christi, Texas | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Duke University Medical Center Durham, North Carolina | |
| East Carolina University Greenville, North Carolina | Site Public Contact - (eubankss@ecu.edu) |
| East Tennessee Childrens Hospital Knoxville, Tennessee | |
| East Tennessee State University Johnson City, Tennessee | Michael D. Hogarty - (HOGARTYM@email.chop.edu) |
| Eastern Maine Medical Center Bangor, Maine | |
| El Paso Children's Hospital El Paso, Texas | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Floating Hospital for Children at Tufts Medical Center Boston, Massachusetts | |
| Florida Hospital Orlando Orlando, Florida | Site Public Contact - (FH.Cancer.Research@flhosp.org) |
| Geisinger Medical Center Danville, Pennsylvania | Site Public Contact - (HemonCCTrials@geisinger.edu) |
| Golisano Children's Hospital of Southwest Florida Fort Myers, Florida | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Greenville Cancer Treatment Center Greenville, South Carolina | |
| HIMA San Pablo Oncologic Hospital Caguas, | |
| Hackensack University Medical Center Hackensack, New Jersey | |
| Helen DeVos Children's Hospital at Spectrum Health Grand Rapids, Michigan | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Henry Ford Hospital Detroit, Michigan | Michael D. Hogarty - (HOGARTYM@email.chop.edu) |
| Hospital for Sick Children Toronto, Ontario | Site Public Contact - (jason.mcguire@sickkids.ca) |
| Hurley Medical Center Flint, Michigan | |
| IWK Health Centre Halifax, Nova Scotia | |
| Inova Fairfax Hospital Falls Church, Virginia | Site Public Contact - (Stephanie.VanBebber@inova.org) |
| Janeway Child Health Centre St. John's, Newfoundland and Labrador | |
| John Hunter Children's Hospital Hunter Regional Mail Centre, New South Wales | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Johns Hopkins All Children's Hospital St. Petersburg, Florida | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland | Site Public Contact - (jhcccro@jhmi.edu) |
| Kaiser Permanente Downey Medical Center Downey, California | |
| Kaiser Permanente Washington Seattle, Washington | Michael D. Hogarty - (HOGARTYM@email.chop.edu) |
| Kaiser Permanente-Oakland Oakland, California | Site Public Contact - (Kpoct@kp.org) |
| Kalamazoo Center for Medical Studies Kalamazoo, Michigan | |
| Kapiolani Medical Center for Women and Children Honolulu, Hawaii | |
| King Faisal Specialist Hospital and Research Centre Riyadh, | |
| Kingston Health Sciences Centre Kingston, Ontario | Site Public Contact - (cc-clinicaltrials@kgh.kari.net) |
| Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, New York | Site Public Contact - (prmc.coordinator@nyumc.org) |
| Lee Memorial Health System Fort Myers, Florida | |
| Legacy Emanuel Children's Hospital Portland, Oregon | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Legacy Emanuel Hospital and Health Center Portland, Oregon | |
| Lehigh Valley Hospital - Muhlenberg Bethlehem, Pennsylvania | |
| Lehigh Valley Hospital-Cedar Crest Allentown, Pennsylvania | Site Public Contact - (stephanie.couch@stjoeshealth.org) |
| Loma Linda University Medical Center Loma Linda, California | |
| Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Torrance, California | |
| Loyola University Medical Center Maywood, Illinois | |
| Lucile Packard Children's Hospital Stanford University Palo Alto, California | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Lurie Children's Hospital-Chicago Chicago, Illinois | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| M D Anderson Cancer Center Houston, Texas | |
| Madigan Army Medical Center Tacoma, Washington | Site Public Contact - (mamcdci@amedd.army.mil) |
| Maimonides Medical Center Brooklyn, New York | Michael D. Hogarty - (HOGARTYM@email.chop.edu) |
| Maine Children's Cancer Program Scarborough, Maine | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Marshfield Medical Center-Marshfield Marshfield, Wisconsin | Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org) |
| Mary Bridge Children's Hospital and Health Center Tacoma, Washington | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Massachusetts General Hospital Cancer Center Boston, Massachusetts | |
| Mattel Children's Hospital UCLA Los Angeles, California | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Mayo Clinic Rochester, Minnesota | |
| McMaster Children's Hospital at Hamilton Health Sciences Hamilton, Ontario | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| MedStar Georgetown University Hospital Washington D.C., District of Columbia | |
| Medical City Dallas Hospital Dallas, Texas | |
| Medical University of South Carolina Charleston, South Carolina | Site Public Contact - (hcc-clinical-trials@musc.edu) |
| Memorial Health University Medical Center Savannah, Georgia | Site Public Contact - (clayter1@memorialhealth.com) |
| Memorial Regional Hospital/Joe DiMaggio Children's Hospital Hollywood, Florida | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Memorial Sloan Kettering Cancer Center New York, New York | |
| Mercy Children's Hospital Toledo, Ohio | |
| Mercy Hospital Saint Louis St Louis, Missouri | |
| Methodist Children's Hospital of South Texas San Antonio, Texas | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Miami Cancer Institute Miami, Florida | Site Public Contact - (cancerinfo@baptisthealth.net) |
| Michigan State University Clinical Center East Lansing, Michigan | |
| Miller Children's and Women's Hospital Long Beach Long Beach, California | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Mission Hospital Inc-Memorial Campus Asheville, North Carolina | Site Public Contact - (leslie.verner@msj.org) |
| Montefiore Medical Center - Moses Campus The Bronx, New York | Site Public Contact - (aaraiza@montefiore.org) |
| Morristown Medical Center Morristown, New Jersey | |
| Mount Sinai Hospital New York, New York | Site Public Contact - (CCTO@mssm.edu) |
| NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, New York | Site Public Contact - (nr2616@cumc.columbia.edu) |
| NYU Winthrop Hospital Mineola, New York | |
| Natalie Warren Bryant Cancer Center at Saint Francis Tulsa, Oklahoma | |
| Nationwide Children's Hospital Columbus, Ohio | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Naval Medical Center - Portsmouth Portsmouth, Virginia | |
| Naval Medical Center -San Diego San Diego, California | |
| Nemours Children's Clinic - Orlando Orlando, Florida | |
| Nemours Children's Clinic - Pensacola Pensacola, Florida | |
| Nemours Children's Clinic-Jacksonville Jacksonville, Florida | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Nemours Children's Hospital Orlando, Florida | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| New York Medical College Valhalla, New York | |
| Newark Beth Israel Medical Center Newark, New Jersey | |
| Nicklaus Children's Hospital Miami, Florida | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Norton Children's Hospital Louisville, Kentucky | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Novant Health Presbyterian Medical Center Charlotte, North Carolina | Site Public Contact - (nnechiporchik@novanthealth.org) |
| Ochsner Medical Center Jefferson New Orleans, Louisiana | Site Public Contact - (Gregory.Johnstone@ochsner.org) |
| Oregon Health and Science University Portland, Oregon | Site Public Contact - (trials@ohsu.edu) |
| Overlook Hospital Summit, New Jersey | |
| Penn State Children's Hospital Hershey, Pennsylvania | |
| Perth Children's Hospital Perth, Western Australia | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Phoenix Childrens Hospital Phoenix, Arizona | |
| Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado | Michael D. Hogarty - (HOGARTYM@email.chop.edu) |
| Primary Children's Hospital Salt Lake City, Utah | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Princess Margaret Hospital for Children Perth, Western Australia | |
| Prisma Health Richland Hospital Columbia, South Carolina | |
| Providence Alaska Medical Center Anchorage, Alaska | Site Public Contact - (AKPAMC.OncologyResearchSupport@providence.org) |
| Providence Sacred Heart Medical Center and Children's Hospital Spokane, Washington | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Queensland Children's Hospital South Brisbane, Queensland | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Rady Children's Hospital - San Diego San Diego, California | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Rainbow Babies and Childrens Hospital Cleveland, Ohio | |
| Rhode Island Hospital Providence, Rhode Island | |
| Riley Hospital for Children Indianapolis, Indiana | |
| Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center Denver, Colorado | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Roswell Park Cancer Institute Buffalo, New York | Site Public Contact - (askroswell@roswellpark.org) |
| Royal Brisbane and Women's Hospital Herston, Queensland | |
| Royal Children's Hospital Parkville, Victoria | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Royal Children's Hospital-Brisbane Herston, Queensland | |
| Rush University Medical Center Chicago, Illinois | Michael D. Hogarty - (HOGARTYM@email.chop.edu) |
| Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital New Brunswick, New Jersey | |
| Saint Barnabas Medical Center Livingston, New Jersey | |
| Saint Christopher's Hospital for Children Philadelphia, Pennsylvania | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Saint Joseph's Hospital/Children's Hospital-Tampa Tampa, Florida | |
| Saint Joseph's Regional Medical Center Paterson, New Jersey | |
| Saint Jude Midwest Affiliate Peoria, Illinois | |
| Saint Luke's Mountain States Tumor Institute Boise, Idaho | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Saint Mary's Hospital Centralia, Illinois | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Saint Peter's University Hospital New Brunswick, New Jersey | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Saint Vincent Hospital Cancer Center Green Bay Green Bay, Wisconsin | Site Public Contact - (Christy.Gilchrist@hshs.org) |
| Saint Vincent Hospital and Health Care Center Indianapolis, Indiana | |
| San Jorge Children's Hospital San Juan, | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Sanford Broadway Medical Center Fargo, North Dakota | Site Public Contact - (OncologyClinicalTrialsFargo@sanfordhealth.org) |
| Sanford USD Medical Center - Sioux Falls Sioux Falls, South Dakota | Site Public Contact - (OncologyClinicalTrialsSF@SanfordHealth.org) |
| Santa Barbara Cottage Hospital Santa Barbara, California | |
| Saskatoon Cancer Centre Saskatoon, Saskatchewan | |
| Scott and White Memorial Hospital Temple, Texas | |
| Seattle Children's Hospital Seattle, Washington | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Sinai Hospital of Baltimore Baltimore, Maryland | Site Public Contact - (pridgely@lifebridgehealth.org) |
| Southern Illinois University School of Medicine Springfield, Illinois | |
| St. Jude Children's Research Hospital Memphis, Tennessee | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Starship Children's Hospital Grafton, Auckland | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| State University of New York Downstate Medical Center Brooklyn, New York | Michael D. Hogarty - (HOGARTYM@email.chop.edu) |
| State University of New York Upstate Medical University Syracuse, New York | |
| Stony Brook University Medical Center Stony Brook, New York | |
| Summerlin Hospital Medical Center Las Vegas, Nevada | Site Public Contact - (research@sncrf.org) |
| Sunrise Hospital and Medical Center Las Vegas, Nevada | Site Public Contact - (research@sncrf.org) |
| Sutter Medical Center Sacramento Sacramento, California | Site Public Contact - (cancerinfo@sutterhealth.org) |
| Swiss Pediatric Oncology Group - Bern Bern, | |
| Swiss Pediatric Oncology Group - Geneva Geneva, | |
| Swiss Pediatric Oncology Group - Lausanne Lausanne, | |
| Sydney Children's Hospital Randwick, New South Wales | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| T C Thompson Children's Hospital Chattanooga, Tennessee | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Tampa General Hospital Tampa, Florida | Site Public Contact - (syapchanyk@tgh.org) |
| Texas Tech University Health Sciences Center-Amarillo Amarillo, Texas | |
| The Children's Hospital at TriStar Centennial Nashville, Tennessee | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| The Children's Hospital at Westmead Westmead, New South Wales | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| The Montreal Children's Hospital of the MUHC Montreal, Quebec | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| The Steven and Alexandra Cohen Children's Medical Center of New York New Hyde Park, New York | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| The Toledo Hospital/Toledo Children's Hospital Toledo, Ohio | |
| The University of Arizona Medical Center-University Campus Tucson, Arizona | |
| Tod Children's Hospital - Forum Health Youngstown, Ohio | Michael D. Hogarty - (HOGARTYM@email.chop.edu) |
| Tripler Army Medical Center Honolulu, Hawaii | |
| Tulane University Health Sciences Center New Orleans, Louisiana | |
| UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California | Michael D. Hogarty - (HOGARTYM@email.chop.edu) |
| UCSF Medical Center-Mission Bay San Francisco, California | |
| UCSF Medical Center-Parnassus San Francisco, California | |
| UF Cancer Center at Orlando Health Orlando, Florida | |
| UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina | Site Public Contact - (cancerclinicaltrials@med.unc.edu) |
| USA Health Strada Patient Care Center Mobile, Alabama | |
| UT Southwestern/Simmons Cancer Center-Dallas Dallas, Texas | Site Public Contact - (canceranswerline@UTSouthwestern.edu) |
| University Medical Center Groningen Groningen, | Michael D. Hogarty - (HOGARTYM@email.chop.edu) |
| University Medical Center of Southern Nevada Las Vegas, Nevada | Site Public Contact - (research@sncrf.org) |
| University Pediatric Hospital San Juan, | |
| University of Alabama at Birmingham Cancer Center Birmingham, Alabama | |
| University of Alberta Hospital Edmonton, Alberta | Site Public Contact - (val.taylor@albertahealthservices.ca) |
| University of Arkansas for Medical Sciences Little Rock, Arkansas | |
| University of California Davis Comprehensive Cancer Center Sacramento, California | |
| University of Chicago Comprehensive Cancer Center Chicago, Illinois | Site Public Contact - (cancerclinicaltrials@bsd.uchicago.edu) |
| University of Florida Health Science Center - Gainesville Gainesville, Florida | Site Public Contact - (cancer-center@ufl.edu) |
| University of Hawaii Cancer Center Honolulu, Hawaii | |
| University of Illinois Chicago, Illinois | |
| University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa | |
| University of Kansas Cancer Center Kansas City, Kansas | Michael D. Hogarty - (HOGARTYM@email.chop.edu) |
| University of Kentucky/Markey Cancer Center Lexington, Kentucky | |
| University of Maryland/Greenebaum Cancer Center Baltimore, Maryland | |
| University of Massachusetts Medical School Worcester, Massachusetts | |
| University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida | |
| University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| University of Mississippi Medical Center Jackson, Mississippi | |
| University of Nebraska Medical Center Omaha, Nebraska | Site Public Contact - (unmcrsa@unmc.edu) |
| University of New Mexico Cancer Center Albuquerque, New Mexico | Site Public Contact - (LByatt@nmcca.org) |
| University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma | Site Public Contact - (ou-clinical-trials@ouhsc.edu) |
| University of Rochester Rochester, New York | |
| University of Texas Health Science Center at San Antonio San Antonio, Texas | Site Public Contact - (phoresearchoffice@uthscsa.edu) |
| University of Texas Medical Branch Galveston, Texas | Michael D. Hogarty - (HOGARTYM@email.chop.edu) |
| University of Vermont and State Agricultural College Burlington, Vermont | Site Public Contact - (rpo@uvm.edu) |
| University of Virginia Cancer Center Charlottesville, Virginia | Site Public Contact - (PAS9E@virginia.edu) |
| University of Wisconsin Hospital and Clinics Madison, Wisconsin | |
| Valley Children's Hospital Madera, California | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Vanderbilt University/Ingram Cancer Center Nashville, Tennessee | |
| Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia | Site Public Contact - (mwellons@vcu.edu) |
| Wake Forest University Health Sciences Winston-Salem, North Carolina | |
| Walter Reed National Military Medical Center Bethesda, Maryland | |
| Washington University School of Medicine St Louis, Missouri | Site Public Contact - (info@siteman.wustl.edu) |
| Wayne State University/Karmanos Cancer Institute Detroit, Michigan | Site Public Contact - (ctoadmin@karmanos.org) |
| West Virginia University Charleston Division Charleston, West Virginia | |
| West Virginia University Healthcare Morgantown, West Virginia | Site Public Contact - (cancertrialsinfo@hsc.wvu.edu) |
| William Beaumont Hospital-Royal Oak Royal Oak, Michigan | |
| Women's and Children's Hospital-Adelaide North Adelaide, South Australia | Site Public Contact - (helpdesk@childrensoncologygroup.org) |
| Yale University New Haven, Connecticut | Site Public Contact - (canceranswers@yale.edu) |
Pathway to Prevention Study
Memoli, Erica, H - erica.memoli@vcuhealth.org
Nelson, Bryce
N/A
NCT00097292
HM20012389
Endocrine, Nutritional And Metabolic Diseases, And Immunity Disorders, Endocrine, Nutritional, Metabolic Diseases, Immunity Disorders (240-279)
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 1 location
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Virginia Commonwealth University Richmond, Virginia | Memoli, Erica, H - (erica.memoli@vcuhealth.org) |
Change in Vaginal Length & Sexual Function in Women Who Undergo Surgery ? RT for Endometrial Cancer
Dodson, Patricia, RN, BSN, CCRC - pwdodson@vcu.edu
Dodson, Patricia, RN, BSN, CCRC
NA
10921
HM20004634
Modality: Radiotherapy
Corpus Uteri
I'm interested
Share via email
Show 1 location
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Virginia Commonwealth University Richmond, Virginia | Dodson, Patricia, RN, BSN, CCRC - (pwdodson@vcu.edu) |
Study of the Natural History of HCC and its Diagnostic, Prognostic Variables and Treatment Outcomes
Lee, Hannah, M. - hannah.lee@vcuhealth.org
Lee, Hannah, M.
N/A
12587
HM20007405
Liver
I'm interested
Share via email
Show 1 location
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Virginia Commonwealth University Richmond, Virginia | Lee, Hannah, M.D. - (hannah.lee1@vcuhealth.org) |
Radiotherapy for Early Stage Palmar and Plantar Fibromatosis
Loyall, Pamela - ployall@vcu.edu
Weiss, Elisabeth
N/A
10906
HM14042
I'm interested
Share via email
Show 1 location
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Virginia Commonwealth University Richmond, Virginia | Williamson, Daeryl, RN - (johnsondl4@vcu.edu) |
Intervention to Reduce HIV Transmission in Economically Disadvantaged Transgender Women
Benotsch, Eric, G - ebenotsch@vcu.edu
Benotsch, Eric, G
Pilot
13748
HM20011245
I'm interested
Share via email
Show 1 location
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Virginia Commonwealth University Richmond, Virginia | Benotsch, Eric, Ph.D. - (ebenotsch@vcu.edu) |
Detection of Urinary Bladder Cancer Using Raman Spectroscopy-Based Screening of Urine
Guruli, Georgi - georgi.guruli@vcuhealth.org
Guruli, Georgi
N/A
12588
HM20006879
Other Urinary, Bladder, Unknown Sites, Kidney, Prostate, Urinary Bladder
I'm interested
Share via email
Show 1 location
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Virginia Commonwealth University Richmond, Virginia | Guruli, Georgi, M.D., Ph.D. - (georgi.guruli@vcuhealth.org) |
Molecular Characterization of Lung Tumors
Deb, Sumitra - sdeb@vcu.edu
Deb, Sumitra
N/A
11995
HM20006524
Lung
I'm interested
Share via email
Show 1 location
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Virginia Commonwealth University Richmond, Virginia |
Southern Virginia Living Well Research and Registry (VLWR)
Thomson, Maria - mthomson2@vcu.edu
Sheppard, Vanessa, B.
N/A
14020
HM20012418
Any Site
I'm interested
Share via email
Show 1 location
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Virginia Commonwealth University Richmond, Virginia | Thomson, Maria, Ph.D. - (mthomson2@vcu.edu) |
A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
Ellie Michalski - emichalski@targetrwe.com
Luketic, Velimir, A
N/A
NCT02815891
HM20010841
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
1\. Adults and children (age 2 or older) being managed or treated for nonalcoholic fatty liver disease. Diagnosis is based on the clinical judgement of the care provider.
Exclusion Criteria:
1\. Inability to provide informed assent/consent. Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 74 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Advanced Gastroenterology Associates, LLC Palm Harbor, Florida | |
| AdventHealth Diabetes Institute Orlando, Florida | |
| Asheville Gastroenterology Associates, PA Asheville, North Carolina | |
| Atlanta Gastroenterology Associates, LLC Atlanta, Georgia | |
| Banner University Medical Center - Phoenix Transplant Center and Advanced Liver Clinic Phoenix, Arizona | |
| Baylor College of Medicine/Texas Children's Hospital Houston, Texas | |
| Bon Secours Liver Institute of Virginia Richmond, Virginia | |
| California Liver Research Institute Pasadena, California | |
| Carteret Medical Group Morehead City, North Carolina | |
| Center for Liver Disease and Transplant at CMC Charlotte, North Carolina | |
| Charite Berlin Berlin, | Markus Reib - (markus.reiss@charite.de) |
| Children's Health - Children's Medical Center Dallas Dallas, Texas | |
| Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania | |
| Cincinnati Children's Hospital Medical Center Cincinnati, Ohio | |
| Cleveland Clinic Children's Cleveland, Ohio | |
| Columbia University Medical Center New York, New York | |
| Connecticut Children's Medical Center Hartford, Connecticut | |
| Connecticut Gastroenterology Hartford, Connecticut | |
| Digestive Health Specialists, PA Winston-Salem, North Carolina | |
| Duke University Medical Center Durham, North Carolina | |
| Emory University - Children's Healthcare of Atlanta Atlanta, Georgia | |
| Gastro Florida Clearwater, Florida | |
| Gastroenterology Associates Greenville, South Carolina | |
| Hospital Clinic i Provincial de Barcelona Barcelona, | Isabel Graupera - (igraupe@clinic.cat) |
| Hospital La Fe Valencia, | Almundena Cubells Garcia - (almudena_cubells@iislafe.es) Laura Consuelo Arnal - (contratos_ec@iislafe.es) |
| Hospital Marques de Valdecilla Santander, Cantabria | Lorena C Estrada - (cayongonzalez@gmail.com) |
| Hospital Virgen del Rocio Seville, | Jose Manuel Caro Vega - (semanekro@gmail.com) Sara Mascort Arques - (sara.mascort@juntadeandalucia.es) |
| Houma Digestive Health Specialists Houma, Louisiana | |
| Indiana University - Division of Gastroenterology and Hepatology Indianapolis, Indiana | |
| Indianapolis Gastroenterology Research Foundation Indianapolis, Indiana | |
| Louisiana Research Center, LLC Shreveport, Louisiana | |
| Mayo Clinic Rochester, Minnesota | |
| Medical University of South Carolina Charleston, South Carolina | |
| Medstar Georgetown Transplant Institute Washington D.C., District of Columbia | |
| Mercy Medical Center Durango, Colorado | |
| NorthShore University Healthsystem Evanston, Illinois | |
| Northwell Health - North Shore University Hospital Manhasset, New York | |
| Northwestern Medicine, Digestive Health Center Chicago, Illinois | |
| Pinnacle Clinical Research Live Oak, Texas | |
| Research Specialists of Texas Houston, Texas | |
| Rush University Medical Center Chicago, Illinois | |
| Rutgers - Robert Wood Johnson Medical School New Brunswick, New Jersey | |
| Saint Louis University - Gastroenterology and Hepatology, Clinical Research Unit St Louis, Missouri | |
| Schiff Center for Liver Disease/University of Miami Miami, Florida | |
| Silicon Valley Research Institute San Jose, California | |
| St. Christopher's Hospital for Children Philadelphia, Pennsylvania | |
| Stanford University Palo Alto, California | |
| Tampa General Medical Group Tampa, Florida | |
| The Children's Hospital at Montefiore, Division of Pediatric GI The Bronx, New York | |
| The Children's Hospital at Oklahoma University Medical Center Oklahoma City, Oklahoma | |
| The Ohio State University Wexner Medical Center Columbus, Ohio | |
| Tulane University School of Medicine New Orleans, Louisiana | |
| UF Health Gastroenterology Jacksonville, Florida | |
| University of California, Davis Sacramento, California | |
| University of Cincinnati Cincinnati, Ohio | |
| University of Colorado Anschutz Medical Campus Aurora, Colorado | |
| University of Florida Gainesville, Florida | |
| University of Florida Hepatology Research at CTRB Gainesville, Florida | |
| University of Iowa Hospitals and Clinics Iowa City, Iowa | |
| University of Louisville Louisville, Kentucky | |
| University of Miami Miami, Florida | |
| University of Michigan Ann Arbor, Michigan | |
| University of Nebraska Medical Center Omaha, Nebraska | |
| University of North Carolina at Chapel Hill Chapel Hill, North Carolina | |
| University of Pennsylvania Philadelphia, Pennsylvania | |
| University of Vermont Medical Center Burlington, Vermont | |
| University of Virginia Charlottesville, Virginia | |
| University of Washington Seattle, Washington | |
| University of Wisconsin Hospital & Clinics Madison, Wisconsin | |
| Universitätsklinikum Aachen Aachen, | Angela Breuer - (angbreuer@ukaachen.de) |
| Universitätsklinikum Frankfurt Frankfurt, | Stefan Zeuzem, MD - (Stefan.Zeuzem@kgu.de) |
| Virginia Commonwealth University Richmond, Virginia | Alanda Perry Jones - (perryar@vcu.edu) |
| Weill Cornell Medical College New York, New York | |
| West Virginia University Morgantown, West Virginia |
Skeletal Muscle Hypertrophy and Cardio-Metabolic Benefits after Spinal Cord Injury
Amos, Tiffany - tiffany.amos@vcuhealth.org
Carter, William, E
N/A
NCT02660073
HM20005018
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 1 location
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Virginia Commonwealth University Richmond, Virginia | Amos, Tiffany - (tiffany.amos@vcuhealth.org) |
A Longitudinal Observational Study of the Natural History and Management of Patients With HCC
Stephanie Harrison - sharrison@targetrwe.com
Lee, Hannah, M.
N/A
NCT02954094
HM20011686
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
• Male or female patients, age ≥18 years
• Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC cholangiocarcinoma may be included; patients who are candidates for surgical and non-surgical treatment, as well as those being followed without specific HCC therapy may be included)
Exclusion Criteria:
• Inability to provide written informed consent
Hepatocellular Cancer
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 72 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| A.O.U.P. di Palermo Palermo, | |
| Banner University Medical Center Phoenix, Arizona | |
| Baylor Scott & White All Saints Fort Worth, Texas | |
| Beth Israel Deaconess Medical Center Boston, Massachusetts | |
| Bon Secours Liver Institute of Virginia Richmond, Virginia | |
| CHU de Nice - Hôpital L'Archet 2 Nice, | |
| California Liver Research Institute Pasadena, California | |
| Center for Liver Disease and Transplant at CMC Charlotte, North Carolina | |
| Charite - Universitatsmedizin Berlin Berlin, | |
| Clinica Universidad de Navarra Pamplona, Navarre | |
| Clinical Research Institute@ Methodist Dallas Medical Center Dallas, Texas | |
| Columbia University New York, New York | |
| Complejo Hospitalario Universitario A Coruna A Coruña, | |
| Emory University Hospital Atlanta, Georgia | |
| Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, | |
| Gastro Florida Clearwater, Florida | |
| Georgetown University Washington D.C., District of Columbia | |
| Harborview Medical Center Seattle, Washington | |
| Henry Ford Health System Detroit, Michigan | |
| Hospital Puerta de Hierro Majadahonda Madrid, | |
| Hospital Universitario Marqués de Valdecilla Santander, | |
| Hospital Universitario Politècnic La Fe Valencia, | |
| Hospital Universitario Virgen del Rocio Seville, | |
| Humanitas Mirasole IRCCS Rozzano, | |
| Hôpitaux Universitaires Paris Centre Paris, | |
| IRCCS "Casa Sollievo della Sofferenza" San Giovanni Rotondo, | |
| Johns Hopkins University Baltimore, Maryland | |
| Mayo Clinic Rochester, Minnesota | |
| Medical University of South Carolina Charleston, South Carolina | |
| Medizinische Hochschule hannover Hanover, Lower Saxony | |
| Mercy Medical Center, GI Research Baltimore, Maryland | |
| NYU Langone Health Brooklyn, New York | |
| Northwell Health - Center for Liver Diseases Manhasset, New York | |
| Northwestern University Division of Gastroenterology and Hepatology Chicago, Illinois | |
| Penn State Hershey Medical Center Hershey, Pennsylvania | |
| Piedmont Atlanta Hospital Atlanta, Georgia | |
| Piedmont Cancer Institute Atlanta, Georgia | |
| Providence Health & Services Cancer Clinical Trials Portland, Oregon | |
| Research Specialists of Texas Houston, Texas | |
| Rush University Medical Center Chicago, Illinois | |
| Rutgers-Robert Wood Johnson Medical School New Brunswick, New Jersey | |
| Saint Louis University St Louis, Missouri | |
| Schiff Center for Liver Diseases/University of Miami Miami, Florida | |
| Southern Therapy and Advanced Research (STAR) LLC Jackson, Mississippi | |
| Stanford University Palo Alto, California | |
| Tampa General Medical Group Tampa, Florida | |
| Tulane University Metairie, Louisiana | |
| Universitatsklinikum Leipzig Leipzig, Saxony | |
| Universitatsmedizin Mainz Mainz, | |
| University of Arkansas Little Rock, Arkansas | |
| University of California San Francisco, California | |
| University of California-Davis Sacramento, California | |
| University of Chicago Chicago, Illinois | |
| University of Florida Health Gastroenterology Jacksonville, Florida | |
| University of Florida Hepatology Research at CTRB Gainesville, Florida | |
| University of Iowa Hospitals and Clinics Iowa City, Iowa | |
| University of Michigan Ann Arbor, Michigan | |
| University of Nebraska Medical Center Omaha, Nebraska | |
| University of North Carolina at Chapel Hill Chapel Hill, North Carolina | |
| University of Pennsylvania Philadelphia, Pennsylvania | |
| University of Southern California/Norris Comprehensive Cancer Center Los Angeles, California | |
| University of Texas Southwestern Medical Center Dallas, Texas | |
| University of Virginia Charlottesville, Virginia | |
| University of Wisconsin Madison, Wisconsin | |
| Universitätsklinikum Aachen Aachen, | |
| Universitätsklinikum Düsseldorf Düsseldorf, | |
| Universitätsklinikum Frankfurt Frankfurt, | |
| Universitätsklinikum Magdeburg Magdeburg, | |
| Vanderbilt University Medical Center - GI Research Office Nashville, Tennessee | |
| Virginia Commonwealth University Richmond, Virginia | |
| Weill Cornell Medical College New York, New York | |
| Wenatchee Valley Hospital & Clinics Wenatchee, Washington |
Cardiac Sarcoidosis Randomized Trial (CHASM-CS-RCT)
David H Birnie, MD - dbirnie@ottawaheart.ca
Kron, Jordana
PHASE3
NCT03593759
HM20014180
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
(i) Cardiac sarcoidosis presenting with one or more of the following clinical findings:
* advanced conduction system disease (defined as Mobitz II AV block or third degree AV block)
* significant sinus node dysfunction (defined as average HR less than 40bpm when awake and/or sustained atrial arrhythmias)
* non- sustained or sustained ventricular arrhythmia
* left ventricular dysfunction (LVEF \< 50%)
* right ventricular dysfunction (RVEF \< 40%)
AND
(ii) No alternative explanation for clinical features
AND
(iii) Nuclear Imaging within six-months of enrollment consisting of FDG-PET scan with FDG uptake suggestive of active CS and myocardial perfusion imaging
AND ONE OR BOTH OF FOLLOWING
(iv) Positive biopsy for Sarcoid (either EMB or extra-cardiac)
(v) CT Chest showing features consistent with pulmonary sarcoidosis and/or mediastinal and/or hilar lymphadenopathy
Exclusion Criteria:
• Current or recent (within two months) non-topical treatment for sarcoidosis
• Current Oral/IV treatment of duration greater than 5 days
• Currently taking Methotrexate or Prednisone for another health condition
• Intolerance or contra-indication to Methotrexate or Prednisone
• Patient does not meet all of the above listed inclusion criteria
• Patient is unable or unwilling to provide informed consent
• Patient is included in another randomized clinical trial
• Patient has a contraindication to PET imaging or is unlikely to tolerate due to severe claustrophobia
• Pregnancy (all women of child bearing age and potential will have a negative BHCG test before enrollment)
• Breastfeeding
• Women of childbearing age who refuse to use a highly effective and medically acceptable form of contraception throughout the study
• Patients for whom the investigator believes that the trial is not in the interest of the patient
DRUG: Prednisone or Prednisolone, DRUG: Methotrexate
Cardiac Sarcoidosis, Sarcoidosis
Cardiac Sarcoidosis, Prednisone (or Prednisolone), Methotrexate
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 30 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Allegheny General Hospital Pittsburgh, Pennsylvania | Indu Poornima, MD - (indu.poornima@ahn.org) |
| CIUSSS de l'Estrie - CHUS - Hôpital Fleurimont Sherbrooke, Quebec | Felix Ayala-Paredes, MD - (felix.ayala-paredes@USherbrooke.ca) |
| CIUSSS-Hopital du Sacre-Coeur de Montreal Montreal, Quebec | Leila Laroussi, MD - (liloularoussi@gmail.com) |
| Chiba University Chiba-sgi, Chiba | |
| Eastern Health Health Sciences Centre St. John's, Newfoundland and Labrador | Stephen Duffett, MD - (sduffett@mun.ca) |
| Hokkaido University Sapporo, Kita 8, Nishi 5, Kita-Ku | Toshiyuki Nagai, MD - (nagai@med.hokudai.ac.jp) |
| Imperial College Healthcare Trust-NHS-Hammersmith Hospital London, | Amanda Varnava, MD - (amanda.varnava@nhs.net) |
| Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval Quebec City, Quebec | Mario Senechal, MD - (Mario.Senechal@criucpq.ulaval.ca) |
| King's College Hospital NHS Foundation Trust London, | Francis D Murgatroyd, MD - (francis.murgatroyd@nhs.net) |
| Libin Cardiovascular Institute of Alberta Calgary, Alberta | Russell Quinn, MD - (frquinn@ucalgary.ca) |
| London Health Sciences Centre London, Ontario | Nikolaos Tzemos, MD - (Niko.Tzemos@lhsc.on.ca) |
| Montefiore Medical Center The Bronx, New York | Yogita Rochlani, MD - (yrochlani@montefiore.org) |
| Montreal Heart Institute Montreal, Quebec | Genevieve Giraldeau, MD - (genevieve.giraldeau@umontreal.ca) |
| Nagoya City University Nagoya, | K Nakasuka, MD - (kosuke.nakasuka@gmail.com) |
| National Cerebral and Cardiovascular Center (NCVC) Osaka, | Kengo Kusano, MD - (kusanokengo@gmail.com) |
| Nippon Medical School Tokyo, | Kenji Yodogawa, MD - (yodo@nms.ac.jp) |
| QE II Health Sciences Centre Halifax, Nova Scotia | Doug Hayami, MD - (doug.hayami@nshealth.ca) |
| Sapporo Medical University Sapporo, | Toshiyuki Yano, MD - (tyano@sapmed.ac.jp) |
| St. Joseph's Healthcare Centre Hamilton, Ontario | Nathan Hambly, MD - (nathan.hambly@medportal.ca) |
| St. Marrianna University Kawasaki, | |
| St. Paul's Hospital Vancouver, British Columbia | Mustafa Toma, MD - (MToma@providencehealth.bc.ca) |
| The Ohio State University Wexner Medical Center Columbus, Ohio | Steven Kalbfleisch, MD - (steven.kalbfleisch@osumc.edu) |
| Tufts Medical Center Boston, Massachusetts | |
| University of Fukui Fukui, | |
| University of Michigan-Michigan Medicine Cardiovascular Center Ann Arbor, Michigan | Todd Koelling, MD - (tkoellin@med.umich.edu) |
| University of Minnesota Minneapolis, Minnesota | |
| University of Ottawa Heart Institute Ottawa, Ontario | David H Birnie, MD - (dbirnie@ottawaheart.ca) |
| University of Utah Salt Lake City, Utah | Line Kemeyou, MD - (line.kemeyou@hsc.utah.edu) |
| Virginia Commonwealth University Richmond, Virginia | Jordana Kron, MD - (jordana.kron@vcuhealth.org) |
| Yale-New Haven Hospital New Haven, Connecticut | Edward Miller, MD - (edward.miller@yale.edu) |
An Open-Label Pilot Study of KPL-914 in Recurrent Pericarditis
Wohlford, George, F - wohlfordgf@vcu.edu
Abbate, Antonio
II
14162
HM20014065
drug: Kpl-914
Diseases of Circulatory System (390-459)
I'm interested
Share via email
Show 1 location
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Virginia Commonwealth University Richmond, Virginia | Wohlford, George, F - (wohlfordgf@vcu.edu) |
Alinity i STAT hsTnI Design Validation Protocol
Ande, Michal - michal.ande@vcuhealth.org
Bachmann, Lorin, M
N/A
14400
HM20014754
Diseases of Circulatory System (390-459)
I'm interested
Share via email
Show 1 location
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Virginia Commonwealth University Richmond, Virginia | Ande, Michal - (michal.ande@vcuhealth.org) |
FSHD Longitudinal Biomarker Preparatory Study
Diaz, Liz, N - Liz.Diaz@vcuhealth.org
Johnson, Nicholas, E
N/A
14497
HM20015068
Diseases of Nervous System and Sense Organs (320-389)
I'm interested
Share via email
Show 1 location
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Virginia Commonwealth University Richmond, Virginia | Diaz, Liz, N - (Liz.Diaz@vcuhealth.org) |
Role of Parents in Adolescent Obesity Treatment: Randomized Control Trial of TEENS+ (TEENS+)
Delorme, Janet - janet.delorme@vcuhealth.org
Bean, Melanie, K.
N/A
14519
HM20014304
Any Site, Any Site
I'm interested
Share via email
Show 1 location
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Virginia Commonwealth University Richmond, Virginia | Delorme, Janet - (janet.delorme@vcuhealth.org) |
Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients with Brain Cancer
Hess, Alison - ahess2@vcu.edu
Chen, Zhi-Jian
I
NCT03423628
HM20012958
Modality: Chemotherapy (nos), Modality: Radiotherapy
Brain and Nervous System
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 1 location
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Virginia Commonwealth University Richmond, Virginia | Reidelbach, Erin - (ejmacdonald@vcu.edu) |
OKRA STUDY (OKRA)
Ruddley, Joyce, R - joyce.ruddley@vcuhealth.org
Kumar, Dhiren
N/A
NCT03326076
HM20012716
Show full eligibility criteria
Hide eligibility criteria
KOAR
• Patient's health care provider adopts and intends to apply the center's AlloSure Routine Testing Schedule as part of the information used to manage the patient.
• Subjects willing to provide written informed consent to participate. KOAR
• Recipients of transplanted organs other than kidney
• Recipients of a transplant from a monozygotic (identical)
• Recipients of a bone marrow transplant
• Recipients who are pregnant
• Recipients who are under the age of 18
• Recipient who are less than 14 days post-transplant
Inclusion Criteria:
• Patient's health care provider adopts and intends to apply the center's AlloSure Routine Testing Schedule as part of the information used to manage the patient.
• Subjects willing to provide written informed consent to participate. KOAR
Exclusion Criteria:
___________________________________________________________
Exclusions for AlloSure? Intended Use
Specimens from patients for whom any of the following are true will not be tested:
• Recipients of transplanted organs other than kidney
• Recipients of a transplant from a monozygotic (identical)
• Recipients of a bone marrow transplant
• Recipients who are pregnant
• Recipients who are under the age of 18
• Recipient who are less than 14 days post-transplant
Diagnostic Test: Donor-derived cell-free DNA (AlloSure?), Other: Standard care, Diagnostic Test: Peripheral blood gene expression profiling (AlloMap Kidney), Diagnostic Test: Analytic platform (IBox)
Kidney Transplant Rejection
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 72 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| AdventHealth Orlando, Florida | Ginnette Guzman - (Ginnette.guzman@adventhealth.com) Daniel Robledo - (daniel.robledo@adventhealth.com) |
| Allegheny General Hospital Pittsburgh, Pennsylvania | Svetlana Bondar - (Svetlana.bondar@ahn.org) |
| Augusta University Augusta, Georgia | Torri Blackmon - (TBLACKM2@augusta.edu) Carol Smith - (CSMITH@augusta.edu) |
| Baylor All Saints Medical Center Fort Worth, Texas | |
| Baylor Scott & White Medical Center Temple, Texas | Rohini Bagewadi - (rohini.bagewadi@BSWHealth.org) Melissa Zdorik - (Melissa.Zdroik1@BSWHealth.org) |
| Beth Israel Deaconess Medical Center Boston, Massachusetts | Susan McDermott - (smcderm2@bidmc.harvard.edu) |
| Brigham and Women's Hospital Boston, Massachusetts | |
| California Pacific Medical Center San Francisco, California | |
| Cedars-Sinai Medical Center Los Angeles, California | Nori Ammerman - (Noriko.Ammerman@cshs.org) |
| Cleveland Clinic - Weston Weston, Florida | Sheilla Jerome - (JEROMES@ccf.org) Luz Arazola - (arazol@ccf.org) |
| Cleveland Clinic Foundation Cleveland, Ohio | Marina Markovic - (markovm@ccf.org) |
| Duke University Durham, North Carolina | Jose Ramos - (jose.ramos@duke.edu) |
| East Carolina University/Vidant Medical Center Greenville, North Carolina | Josh Yang - (YANGJ15@ECU.EDU) |
| Erie County Medical Center Buffalo, New York | Danielle Wittek - (dwittek@ecmc.edu) |
| Geisinger Clinic Danville, Pennsylvania | Natacha Antunes - (nmantunes@geisinger.edu) |
| George Washington University Washington D.C., District of Columbia | Sarah Andrews - (scandrews@mfa.gwu.edu) |
| Georgetown University Washington D.C., District of Columbia | |
| Hospital of the University of Pennsylvania Philadelphia, Pennsylvania | Robin Neubauer - (Robin.Neubauer@uphs.upenn.edu) |
| Houston Methodist Hospital Houston, Texas | |
| Indiana University Indianapolis, Indiana | Margaret Adebiyi - (madebiyi@iu.edu) |
| Inova Fairfax Hospital Falls Church, Virginia | Percy Julian - (Percy.Julian@inova.org) Sarah Wright - (Sarah.Wright@inova.org) |
| Integris Baptist Medical Center Oklahoma City, Oklahoma | Della Dion - (della.dion@integrisok.com) |
| Intermountain Medical Center Murray, Utah | |
| Johns Hopkins University Baltimore, Maryland | Alyssa Smith - (asmit199@jhmi.edu) Obi Ezennia - (oezenni1@jhmi.edu) |
| Loma Linda Medical Center Loma Linda, California | Andrea Pinto - (APinto@llu.edu) |
| Loyola University Maywood, Illinois | Ted Clevy-Schneller - (Ted.Clevy-schneller@luhs.org) Sana Iqbal - (siqbal5@luc.edu) |
| Massachusetts General Hospital Boston, Massachusetts | Margaret V Thomas - (MVTHOMAS@mgh.harvard.edu) |
| Medical University of South Carolina Charleston, South Carolina | |
| Methodist Healthcare Foundation Memphis, Tennessee | Joseph Youngman - (jyoungman@uthsc.edu) Marisa Wong - (mwong2@uthsc.edu) |
| Metrolina Nephrology Associates Charlotte, North Carolina | Debi Wright - (dwright@metrolinanephrology.com) |
| Montefiore Medical Center The Bronx, New York | Omar Mohammed - (OMOHAMME@montefiore.org) |
| Ochsner Foundation Hospital New Orleans, Louisiana | Angela Smith - (anglsmith@ochsner.org) |
| Ohio State University Medical Center Columbus, Ohio | Margaret Wuebker - (Margaret.Wuebker@osumc.edu) |
| Rhode Island Hospital Providence, Rhode Island | Andrea Viera - (Andrea.Vieira@Lifespan.org) Kylie Freer - (kylie.freer1@lifespan.org) |
| Rush University Medical Center Chicago, Illinois | Sherri Loeb - (Sherri_t_loeb@rush.edu) |
| SUNY Downstate Medical Center Brooklyn, New York | Seema Chittalae - (Seema.Chittalae@downstate.edu) |
| Sacred Heart Medical Center Eugene, Oregon | Lisa Passey - (lisa.passey@providence.org) |
| Saint Barnabus Medical Center Livingston, New Jersey | Ana Merced - (ana.merced@rwjbh.org) |
| Stanford Health Care San Jose, California | Asha Shori - (ashas@stanford.edu) Will Ngo - (wngo008@stanford.edu) |
| Tampa General Hospital Tampa, Florida | |
| Texas Research Institute Fort Worth, Texas | |
| The Oklahoma Transplant Center at OU Medical Center Oklahoma City, Oklahoma | Julie Choate - (Julie.choate@oumedicine.com) |
| The University of Missouri Columbia, Missouri | Mihiri De Silva - (desilvam@health.missouri.edu) |
| Tulane University Medical Center New Orleans, Louisiana | Nicole Lassair - (nlassair@tulane.edu) |
| UC Davis Medical Center Sacramento, California | Katherine Howes - (khowes@ucdavis.edu) |
| UT Health San Antonio San Antonio, Texas | Jillian Woodsworth - (woodworthj@uthscsa.edu) |
| UT Southwestern Dallas, Texas | Whitney Baah - (Witney.Baah@UTSouthwestern.edu) Kazi Moon - (KaziMoon.Moonmoon@UTSouthwestern.edu) |
| University of Alabama at Birmingham Birmingham, Alabama | Tina Parkhill - (tparkhill@uabmc.edu) |
| University of California San Francisco San Francisco, California | Gabriel Garcia - (Gabriel.Garcia@ucsf.edu) |
| University of California, Los Angeles Los Angeles, California | Janette Gadzhyan - (JGadzhyan@mednet.ucla.edu) |
| University of Chicago Chicago, Illinois | Jyotsna Soundararajan - (jsoundararajan@medicine.bsd.uchicago.edu) |
| University of Colorado Hospital Aurora, Colorado | |
| University of Colorado- Anschutz Medical Campus Aurora, Colorado | Lisa Kornfeld - (LISA.KORNFELD@CUANSCHUTZ.EDU) |
| University of Illinois at Chicago Chicago, Illinois | |
| University of Kansas Medical Center Kansas City, Kansas | Erin Delaney - (edelaney@kumc.edu) |
| University of Kentucky Chandler Hospital Lexington, Kentucky | Deepa Valvi - (deepa.valvi@uky.edu) |
| University of Maryland Baltimore, Maryland | Amanda Bartosic - (ABartosic@som.umaryland.edu) Veronica Brown - (VLBrown@som.umaryland.edu) |
| University of Miami/Jackson Memorial Hospital Miami, Florida | |
| University of Minnesota Medical Center Minneapolis, Minnesota | |
| University of Mississippi Medical Center Jackson, Mississippi | Delia Owens - (dyowens@umc.edu) |
| University of Nebraska Medical Center Omaha, Nebraska | Katie Ostlund - (katie.ostlund@unmc.edu) |
| University of Pittsburgh Medical Center Pittsburgh, Pennsylvania | Michelle Lucas - (mcmeansmm2@upmc.edu) |
| University of Southern California Los Angeles, California | Daisy Rios |
| University of Utah Salt Lake City, Utah | Amber Lamph - (Amber.Lamph@hsc.utah.edu) |
| University of Washington Medical Center Seattle, Washington | Belinda Pan - (bcpan@uw.edu) |
| Vanderbilt University Medical Center Nashville, Tennessee | Malia Reed - (malia.reed@vanderbilt.edu) |
| Virginia Commonwealth University Richmond, Virginia | Joyce Ruddley - (joyce.ruddley@vcuhealth.org) |
| Wake Forest Baptist Medical Center- Department of General Surgery Winston-Salem, North Carolina | Gwen McPherson - (gmcphers@wakehealth.edu) |
| Washington University St Louis, Missouri | |
| Washington University (Barnes Jewish Hospital) Saint Louis, Missouri | Devin Wall - (devinwall@wustl.edu) |
| Willis-Knighton Physician Network/ John C. McDonald Regional Transplant Center Shreveport, Louisiana | Sherry Stephens - (sstephens2@wkhs.com) Amanda Glass - (aglass@wkhs.com) |
| Yale University New Haven, Connecticut | Daksshi Hettiarachichi - (daksshi.hettiarachchi@yale.edu) |
Study of INTERCEPT in Regions at Potential Risk for Zika Virus Tranfusion-Transmitted Infections (RedeS)
Fremeau, Jacqueline - jacqueline.barnhardt@vcuhealth.org
Green, Jeffrey, A
III
NCT03037164
HM20013456
Show full eligibility criteria
Hide eligibility criteria
Stage A:
• Age ? 4 years.
• Patients who require or are expected to require a transfusion of RBC component(s), including red cell exchange transfusion
• Signed and dated informed consent form.
• Female patients of child-bearing potential must:
• Have negative serum or urine pregnancy tests prior to study treatment to rule out pregnancy, and
• Agree to use to use at least one method of birth control that results in a low failure rate (i.e., less than 1% per year) when used consistently and correctly such as implants, injectables, combined oral contraceptives, some intrauterine devices (IUDs), sexual abstinence or vasectomized partner for the duration of study participation and an additional 28 days. For 28-day +6-month extension study in chronically transfused patients: ? A diagnosis of a bone marrow failure syndrome requiring repeated RBC transfusion for congenital or acquired chronic anemia (e.g., sickle cell anemia, thalassemia, other hemoglobinopathies, myelodysplastic syndrome, aplastic anemia, chemotherapy or stem cell transplant etc.) For 28-day +6-month extension study in SCD patients requiring regular repeated RCE.
• Diagnosis of SCD, either HbSS, HbSC or HbSB0 thalassemia, confirmed by Hb electrophoresis, deoxyribonucleic acid (DNA) analysis or high-performance liquid chromatography (HPLC)
• Currently participating in an automated RCE transfusion program (for at least 3 months prior to enrollment) with 3-to-8 week intervals between RCE transfusion episodes Stage A: Exclusion Criteria
• Confirmed positive baseline serum/plasma antibody specific to IBS RBC (S 303 treated RBC) as determined by INTERCEPT S 303 antibody screening panel prior to receiving the first study transfusion
• Pregnant or breast feeding.
• Presence of an RBC warm autoantibody with evidence of active hemolysis.
• Positive DAT as defined below:
• A polyspecific-DAT reaction strength > 2+, or
• A polyspecific-DAT (any strength) in conjunction with pan-reactivity with a commercial IAT antibody screening panel that precludes the identification of underlying alloantibodies or indicates the presence of autoantibody.
• Have had an RBC transfusion within 7 days prior to randomization.
• Have received investigational products, including investigational blood products, pharmacologic agents or imaging materials, within 28 days prior to randomization. Prior receipt of conventional blood products tested with an investigational NAT test is not considered ground for exclusion.
• Patients presenting with or expected to have massive hemorrhage (?10 RBC units within 24 hours) or expected to require massive transfusion protocols. Planned red cell exchange does not apply.
• Patients who require neonatal transfusions and intrauterine transfusions.
• Pre-existing antibody to RBC antigens that may make the provision of compatible study RBC components difficult.
• History of transfusion reactions requiring washed RBCs, volume reduced RBC, or RBCs with additive solution removed.
• Patients with documented IgA deficiency or a history of severe allergic reactions to blood products.
• For SCD patients to be enrolled into the repeated RCE 28-day +6-month arm of the study:
• A history of acute chest syndrome in the last 6 months, or hyperhemolysis syndrome at any time.
• Clinical evidence of splenic hyperfunction or splenic enlargement: ?18 cm in longitudinal diameter (diagnosed at the Investigator's discretion according to the data available, with ultrasound data being preferable).
• Currently receiving chemotherapy for treatment of cancer. Hydroxyurea for SCD is acceptable if subject has been on stable therapy for 3 months and no changes to dosage are planned.
• Subject is in active treatment with renal dialysis.
• Any subject for whom a substantial change in the number of RBC components transfused is anticipated due to anticipated splenectomy, bone marrow transplant, surgery or other change in clinical status.
• Subject with known G6PD deficiency or requiring treatment with medications that are known to adversely affect RBC viability or bone marrow function.
Inclusion Criteria:
• Age ? 4 years.
• Patients who require or are expected to require a transfusion of RBC component(s), including red cell exchange transfusion
• Signed and dated informed consent form.
• Female patients of child-bearing potential must:
• Have negative serum or urine pregnancy tests prior to study treatment to rule out pregnancy, and
• Agree to use to use at least one method of birth control that results in a low failure rate (i.e., less than 1% per year) when used consistently and correctly such as implants, injectables, combined oral contraceptives, some intrauterine devices (IUDs), sexual abstinence or vasectomized partner for the duration of study participation and an additional 28 days. For 28-day +6-month extension study in chronically transfused patients: ? A diagnosis of a bone marrow failure syndrome requiring repeated RBC transfusion for congenital or acquired chronic anemia (e.g., sickle cell anemia, thalassemia, other hemoglobinopathies, myelodysplastic syndrome, aplastic anemia, chemotherapy or stem cell transplant etc.) For 28-day +6-month extension study in SCD patients requiring regular repeated RCE.
• Diagnosis of SCD, either HbSS, HbSC or HbSB0 thalassemia, confirmed by Hb electrophoresis, deoxyribonucleic acid (DNA) analysis or high-performance liquid chromatography (HPLC)
• Currently participating in an automated RCE transfusion program (for at least 3 months prior to enrollment) with 3-to-8 week intervals between RCE transfusion episodes Stage A: Exclusion Criteria
• Confirmed positive baseline serum/plasma antibody specific to IBS RBC (S 303 treated RBC) as determined by INTERCEPT S 303 antibody screening panel prior to receiving the first study transfusion
• Pregnant or breast feeding.
• Presence of an RBC warm autoantibody with evidence of active hemolysis.
• Positive DAT as defined below:
• A polyspecific-DAT reaction strength > 2+, or
• A polyspecific-DAT (any strength) in conjunction with pan-reactivity with a commercial IAT antibody screening panel that precludes the identification of underlying alloantibodies or indicates the presence of autoantibody.
• Have had an RBC transfusion within 7 days prior to randomization.
• Have received investigational products, including investigational blood products, pharmacologic agents or imaging materials, within 28 days prior to randomization. Prior receipt of conventional blood products tested with an investigational NAT test is not considered ground for exclusion.
• Patients presenting with or expected to have massive hemorrhage (?10 RBC units within 24 hours) or expected to require massive transfusion protocols. Planned red cell exchange does not apply.
• Patients who require neonatal transfusions and intrauterine transfusions.
• Pre-existing antibody to RBC antigens that may make the provision of compatible study RBC components difficult.
• History of transfusion reactions requiring washed RBCs, volume reduced RBC, or RBCs with additive solution removed.
• Patients with documented IgA deficiency or a history of severe allergic reactions to blood products.
• For SCD patients to be enrolled into the repeated RCE 28-day +6-month arm of the study:
• A history of acute chest syndrome in the last 6 months, or hyperhemolysis syndrome at any time.
• Clinical evidence of splenic hyperfunction or splenic enlargement: ?18 cm in longitudinal diameter (diagnosed at the Investigator's discretion according to the data available, with ultrasound data being preferable).
• Currently receiving chemotherapy for treatment of cancer. Hydroxyurea for SCD is acceptable if subject has been on stable therapy for 3 months and no changes to dosage are planned.
• Subject is in active treatment with renal dialysis.
• Any subject for whom a substantial change in the number of RBC components transfused is anticipated due to anticipated splenectomy, bone marrow transplant, surgery or other change in clinical status.
• Subject with known G6PD deficiency or requiring treatment with medications that are known to adversely affect RBC viability or bone marrow function.
Device: INTERCEPT Blood System for Red Blood Cells, Device: Conventional (Control)
Anemia
INTERCEPT, Red Blood Cells, RBC, Pathogen Inactivation, Zika, Cerus, Pathogen Reduction
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 9 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Baylor St. Luke's Medical Center Houston, Texas | Arthur Bracey, MD - (arthur.bracey@commonspirit.org) |
| Grady Health System Atlanta, Georgia | Ross Fasano, MD - (scdresearch@emory.edu) Hailly Butler, BSN |
| HIMA San Pablo Hospital Caguas, | |
| Mayo Clinic Jacksonville Jacksonville, Florida | |
| Menonita General Hospital Aibonito, | |
| San Juan Bautista School of Medicine Clinical Research Unit Caguas, | |
| UT Southwestern Medical Center Dallas, Texas | Ravi Sarode, MD - (Ravi.Sarode@UTSouthwestern.edu) |
| Virginia Commonwealth University Richmond, Virginia | Jeffrey A Green, Dr - (jeffrey.green@vcuhealth.org) |
| Yale University New Haven, Connecticut |
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1
Howell, Jodie - jodie.howell@vcuhealth.org
Johnson, Nicholas, E
N/A
14536
HM20014419
Diseases of Musculoskeletal System and Connective Tissue (710-739), Diseases of Musculoskeletal System and Connective Tissue (710-739), Diseases of Musculoskeletal System and Connective Tissue (710-739)
I'm interested
Share via email
Show 1 location
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Virginia Commonwealth University Richmond, Virginia | Holmberg, Brittney, A - (Brittney.Holmberg@vcuhealth.org) |
Use of Simultaneous Multi-Slice Imaging for Pediatric Brain MRI Compared with Standard TSE Sequences
Lessard, Margaret - margaret.lessard@vcuhealth.org
Vorona, Gregory
N/A
14702
HM20014210
I'm interested
Share via email
Show 1 location
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Virginia Commonwealth University Richmond, Virginia | Lessard, Margaret - (margaret.lessard@vcuhealth.org) |
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) (TRANSCEND )
BMS Study Connect Contact Center www.BMSStudyConnect.com - Clinical.Trials@bms.com
McCarty, John, M.
PHASE1
NCT03331198
HM20016147
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* Diagnosis of:
• CLL with an indication for treatment based on the Investigator's opinion and measurable disease, or
• SLL (lymphadenopathy and/or splenomegaly and \< 5×10\^9 CD19+ CD5+ clonal B lymphocytes/L \[\< 5000/µL\] in the peripheral blood at diagnosis with measurable disease that is biopsy-proven SLL) * Subjects (other than those in the ibrutinib + JCAR017 combination therapy and DEME cohort) must have received and failed Bruton tyrosine kinase inhibitor (BTKi) treatment or have been deemed ineligible for BTKi therapy. * Subjects in the JCAR017 monotherapy cohorts must have received previous treatment as follows:
• Monotherapy cohorts EXCEPT DEME cohort: Subjects with CLL or SLL and high-risk features must have failed at least 2 lines of prior therapy.
• Monotherapy cohorts EXCEPT DEME cohort: Subjects with CLL or SLL and standard-risk features must have failed at least 3 lines of prior therapy.
• DEME cohort ONLY: Subjects with relapsed or refractory CLL or SLL, irrespective of cytogenetic risk features, must have received at least 2 lines of prior therapy including a BTKi and a BCL2i. * Subjects in the ibrutinib + JCAR017 combination therapy cohort must either:
• be receiving ibrutinib and progressing at the time of study enrollment
• be receiving ibrutinib for at least 6 months with a response less than complete response/remission (CR) and have high-risk features as defined in inclusion criterion 5a
• have BTK or PLCgamma2 mutations per local laboratory assessment, with or without progression on ibrutinib
• have previously received ibrutinib and have no contraindications to restarting ibrutinib * Eastern Cooperative Oncology Group performance status of ≤ 1 * Assessed by the Investigator to have adequate bone marrow function to receive lymphodepleting chemotherapy * Adequate organ function, defined as:
• Serum creatinine ≤ 1.5 × age-adjusted upper limit of normal (ULN) OR calculated creatinine clearance \> 30 mL/min
• Alanine aminotransferase ≤ 5 × ULN and total bilirubin \< 2.0 mg/dL (or \< 3.0 mg/dL for subjects with Gilbert's syndrome or leukemic infiltration of the liver)
• Adequate pulmonary function, defined as ≤ Common Terminology Criteria for Adverse Events (CTCAE) Grade 1 dyspnea and saturated oxygen (SaO2) ≥ 92% on room air
• Adequate cardiac function, defined as left ventricular ejection fraction ≥ 40% as assessed by echocardiogram or multiple uptake gated acquisition scan performed within 30 days prior to determination of eligibility * Subject either currently has central vascular access or is a candidate to receive central vascular access or peripheral vascular access for leukapheresis procedure. * If prior CD19-targeted therapy has been administered, subject must have CD19-positive disease confirmed by immunohistochemistry or flow cytometry since completing the prior CD19-targeted therapy. * Subjects in ibrutinib + JCAR017 combination cohort must have progressed on a BTKi and have received prior therapy with venetoclax * Subjects in venetoclax + JCAR017 combination cohort must:
• have failed at least 1 prior line of therapy, including failed BTKi therapy or have been deemed ineligible to receive BTKi
• be venetoclax naive (required for dose expansion) or
• if prior venetoclax (only for dose escalation)
• have no contraindictions to re-initiation of venetoclax based on prior intolerance and have had at least 6 months elapsed since the last dose of venetoclax, if either, best response was stable disease, or subject experienced disease progression on venetoclax, or within 6 months of venetoclax discontinuation * subjects in the venetoclax + JCAR017 combination must have hemoglobin \>=9 g/dL, absolute neutrophil count \>=500mm3 and platelets\>= 75,000/mm3, unless cytopenias are judged by investigator to be due to CLL infiltration of the bone marrow * must have diagnosis of CLL or SLL with an indication for treatment based on the investigator's opinion and measurable disease (any of the following measurable lymph nodes ≥1.5 cm in the greatest transverse diameter and/or hepatomegaly or splenomegaly) and demonstration of CLL cells in the peripheral blood by flow cytometry
Exclusion Criteria:
* Subjects with known active central nervous system (CNS) involvement by malignancy. Those with prior CNS disease that has been effectively treated will be eligible if treatment was completed at least 3 months prior to enrollment with no evidence of symptomatic disease and stable abnormalities on repeat imaging.
* History of another primary malignancy that has not been in remission for at least 2 years. (The following are exempt from the 2-year limit: nonmelanoma skin cancer, completely resected stage 1 solid tumor with low risk for recurrence, curatively treated localized prostate cancer, cervical carcinoma in situ on biopsy or a squamous intraepithelial lesion on Pap smear, and in situ breast cancer that has been completely resected.)
* Subjects with Richter's transformation
* Prior treatment with any gene therapy product
* Active hepatitis B, active hepatitis C, or active human immunodeficiency virus (HIV) infection
* Systemic fungal, bacterial, viral, or other infection that is not controlled
* Presence of acute or extensive chronic graft versus host disease (GVHD)
* History of any one of the following cardiovascular conditions within the past 6 months: Class III or IV heart failure as defined by the New York Heart Association (NYHA), cardiac angioplasty or stenting, myocardial infarction, unstable angina, or other clinically significant cardiac disease
* History or presence of clinically relevant CNS pathology such as epilepsy, generalized seizure disorder, aphasia, stroke with current neurologic sequelae, severe brain injuries, dementia, Parkinson's disease, cerebellar disease,cerebral edema, or psychosis
* Pregnant or nursing (lactating) women
* Use of any of the following medications or treatments within the noted time prior to leukapheresis:
• Alemtuzumab within 6 months prior to leukapheresis
• Allogeneic hematopoietic stem cell transplant within 100 days prior to leukapheresis
• Cladribine within 3 months prior to leukapheresis
• Donor lymphocyte infusions (DLI) within 2 months prior to leukapheresis
• Radiation including large bone marrow fields such as sternum or pelvis within 6 weeks prior to leukapheresis
• Fludarabine within 4 weeks prior to leukapheresis
• GVHD therapies such as calcineurin inhibitors, methotrexate or other chemotherapeutics, mycophenolate mofetil, rapamycin, or immunosuppressive antibodies (such as anti-tumor necrosis factor-α \[TNFα\], anti-interleukin-6 \[IL-6\], or anti-interleukin-6 receptor \[IL 6R\]) within 4 weeks prior to leukapheresis
• Cyclophosphamide, ifosfamide, bendamustine, chlorambucil, or melphalan within 2 weeks prior to leukapheresis
• Therapeutic doses of corticosteroids (defined as \> 20 mg/day prednisone or equivalent) within 7 days prior to leukapheresis
• Anti-CD20 monoclonal antibodies within 7 days prior to leukapheresis
• Venetoclax within 4 days prior to leukapheresis
• Idelalisib or duvelisib within 2 days prior to leukapheresis
• Lenalidomide or covalent and non-covalent BTKi within 1 day prior to leukapheresis
• Experimental agents, including off-label use of approved drugs (with the exception of acalabrutinib which may be continued up to the day before leukapheresis), within 4 weeks prior to leukapheresis unless progression is documented on the experimental therapy and at least 3 half-lives have elapsed prior to leukapheresis * Uncontrolled medical, psychological, familial, sociological, or geographical conditions that do not permit compliance with the protocol, as judged by the Investigator; or subject unwillingness or inability to follow the procedures required in the protocol * Progressive vascular tumor invasion, thrombosis, or embolism * Deep vein thrombosis or embolism not managed on a stable regimen of anticoagulation * Use of any of the following medications or treatments within the noted time prior to leukapheresis lenalidomide or acalabrutinib within 1 day prior to leukapheresis experimental agents, including off-label use of approved drugs, within 4 weeks prior to leukapheresis. * Venous thrombosis or embolism requiring treatment but not managed on a stable regimen of anticoagulation * For subjects in the venetoclax + JCAR017 combination cohorts only, concomitant treatment with CYP3A moderate/strong inducers or moderate/strong inhibitors which cannot be discontinued
BIOLOGICAL: JCAR017 (lisocabtagene maraleucel), BIOLOGICAL: JCAR017 (lisocabtagene maraleucel) + ibrutinib, BIOLOGICAL: JCAR017 (lisocabtagene maraleucel) + venetoclax
Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Small Lymphocytic
TRANSCEND_CLL_004
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 85 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Astera Cancer Care East Brunswick, New Jersey | |
| Atlantic Health System / Morristown Medical Center Morristown, New Jersey | |
| Banner MD Anderson Cancer Center Gilbert, Arizona | Brenda Noggy - (brenda.noggy@bannerhealth.com) |
| Banner MD Anderson Cancer Center Gilbert, Arizona | |
| Barbara Ann Karmanos Cancer Institute Detroit, Michigan | Joo En Kim, MPH - (kimjo@karmanos.org) |
| Baylor University Medical Center Dallas, Texas | |
| Beth Israel Deaconess Medical Center Boston, Massachusetts | Emma Logan, RN - (eklogan@bidmc.harvard.edu) Pavania Elavalakanar - (pelavala@bidmc.harvard.edu) |
| City of Hope Duarte, California | Hormoz Mirshkarlo, MD - (hmirshkarlo@coh.org) |
| City of Hope Duarte, California | |
| Colorado Blood Cancer Institute Denver, Colorado | |
| Columbia University Medical Center New York, New York | |
| Duke University Medical Center Durham, North Carolina | |
| Duke University Medical Center Durham, North Carolina | Rachel Stowe - (rachel.stowe@duke.edu) Danielle M Brander, MD - (danielle.brander@duke.edu) |
| Franciscan St. Francis Health - Indiana Blood and Marrow Transplantation (IBMT) Indianapolis, Indiana | |
| Fred Hutchinson Cancer Research Center Seattle, Washington | SCCA Immunotherapy Trials Intake - (immunotherapy@seattlecca.org) |
| Froedtert Hospital BMT Medical College of Wisconsin Milwaukee, Wisconsin | |
| Georgetown University Medical Center Washington D.C., District of Columbia | Pari Ramzi - (ramzip1@georgetown.edu) |
| Hackensack University Medical Center Hackensack, New Jersey | Kara Yannotti, RNC - (Kara.Yannotti@Hackensackmeridian.org) |
| Huntsman Cancer Institute Salt Lake City, Utah | Kolleen Hicks, BS - (Kolleen.Hicks@hci.utah.edu) |
| John Theurer Cancer Center Hackensack, New Jersey | |
| Local Institution - 0001 Lenexa, Kansas | |
| Local Institution - 0005 Leeds, | |
| Local Institution - 0010 San Francisco, California | |
| Local Institution - 0015 Boston, Massachusetts | |
| Local Institution - 0018 Seattle, Washington | |
| Local Institution - 0019 Atlanta, Georgia | |
| Local Institution - 0026 New York, New York | |
| Local Institution - 0027 New Orleans, Louisiana | |
| Local Institution - 0028 Salt Lake City, Utah | |
| Local Institution - 0029 Pittsburgh, Pennsylvania | |
| Local Institution - 0035 New York, New York | |
| Local Institution - 0059 Los Angeles, California | |
| Local Institution - 0062 Detroit, Michigan | |
| Local Institution - 0077 New Brunswick, New Jersey | |
| Local Institution - 0079 Dallas, Texas | |
| Local Institution - 0083 Dallas, Texas | |
| Local Institution - 0085 Washington D.C., District of Columbia | |
| Local Institution - 0087 Richmond, Virginia | |
| Local Institution - 0098 Porto, | |
| Local Institution - 0104 Atlanta, Georgia | |
| Local Institution - 0107 Wichita, Kansas | |
| Local Institution - 0109 Chile, Santiago Metropolitan | |
| Local Institution - 0110 Newark, Delaware | |
| Local Institution - 0112 Toronto, Ontario | |
| Local Institution - 0113 Charlottesville, Virginia | |
| Massachusetts General Hospital Boston, Massachusetts | Jacob D Soumerai, MD - (jsoumerai@mgh.harvard.edu) |
| Mayo Clinic Rochester, Minnesota | Mohamed Kharfan-Dabaja, MD - (kharfandabaja.mohamed@mayo.edu) Teresa Banda - (teresa.banda@bswhealth.org) |
| Mayo Clinic Rochester, Minnesota | Gabrielle Bouska - (bouska.gabrielle@mayo.edu) |
| Mayo Clinic Rochester, Minnesota | |
| Mayo Clinic - Jacksonville Jacksonville, Florida | |
| Medical College of Wisconsin Milwaukee, Wisconsin | Nirav Shah, MD - (nishah@mcw.edu) |
| Northwestern Memorial Hospital Chicago, Illinois | |
| Northwestern University Chicago, Illinois | Study Coordinator - (cancertrials@northwestern.edu) Arezou Ireta - (a-ireta@northwestern.edu) |
| Norton Healthcare - Norton Cancer Institute Louisville, Kentucky | |
| Princess Margaret Cancer Centre Toronto, Ontario | |
| Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey | Oona Harrigan - (oh77@cinj.rutgers.edu) Roger Strair, MD, PhD - (strairrk@cinj.rutgers.edu) |
| Stony Brook University Stony Brook, New York | |
| The Blood and Marrow Transplant Group of Georgia (BMTGA) Atlanta, Georgia | Scott R Solomon, MD - (ssolomon@bmtga.com) Stacey Brown - (Stacey.brown@northside.com) |
| The Ohio State University Comprehensive Cancer Center Columbus, Ohio | |
| The University of Texas - MD Anderson Cancer Center Houston, Texas | |
| The University of Texas MD Anderson Cancer Center Houston, Texas | William G Wierda, MD, PhD - (wwierda@mdanderson.org) |
| Thomas Jefferson University Philadelphia, Pennsylvania | Allison Scott - (allison.scott@jefferson.edu) |
| Thomas Jefferson University - Clinical Research Institute Philadelphia, Pennsylvania | |
| UC San Diego Moores Cancer Center La Jolla, California | Krisma C Montalvo - (kcmontalvo@ucsd.edu) Kimberly Aguilar - (k1aguilar@ucsd.edu) |
| UPMC Hillman Cancer Center Pittsburgh, Pennsylvania | - (fukaslj@upmc.edu) |
| University Hospitals Cleveland Medical Center Cleveland, Ohio | |
| University Hospitals Seidman Cancer Center (Case Western) Cleveland, Ohio | Paolo Caimi, MD - (Paolo.Caimi@UHhospitals.org) Yeritza Hernandez-Collazo, MS - (Yeritza.Hernandez-Collazo@UHhospitals.org) |
| University of Alabama Birmingham Birmingham, Alabama | |
| University of Alabama at Birmingham Birmingham, Alabama | Tiffany Hill - (tiffanydhill@uabmc.edu) Danielle Mussey - (dmussey@uabmc.edu) |
| University of California San Diego Moores Cancer Center La Jolla, California | |
| University of California, Los Angeles Los Angeles, California | Joy Valadez - (jvaladez@mednet.ucla.edu) Anna Crosetti - (acrosetti@mednet.ucla.edu) |
| University of California, San Francisco San Francisco, California | Andrew Chon - (andrew.chon@ucsf.edu) |
| University of Chicago Medical Center Chicago, Illinois | Sadi Dixon, RN - (sdixon2@medicine.bsd.uchicago.edu) Elaine Hoekstra - (ehoekstra1@medicine.bsd.uchicago.edu) |
| University of Chicago Medical Center Chicago, Illinois | |
| University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan | |
| University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan | |
| University of Nebraska Medical Center Omaha, Nebraska | Gail A Paulsen - (gpaulsen@unmc.edu) Lindsay Hicks - (lindsay.hick@unmc.edu) |
| University of Nebraska Medical Center Omaha, Nebraska | |
| University of Oklahoma Health Sciences Center (Stephenson Cancer Center) Oklahoma City, Oklahoma | Adam Asch, MD - (adam-asch@ouhsc.edu) |
| University of Oklahoma Peggy and Charles Stephenson Cancer Center Oklahoma City, Oklahoma | |
| University of Pennsylvania - Perelman Center for Advanced Medicine Philadelphia, Pennsylvania | |
| University of Pennsylvania Perelman Center for Advanced Medicine Philadelphia, Pennsylvania | Stephen Schuster, MD - (stephen.schuster@uphs.upenn.edu) |
| University of Texas Southwestern Medical Center Dallas, Texas | Courtney Saltarski - (courtney.saltarski@utsouthwestern.edu) Farrukh Awan, MD - (farrukh.awan@utsouthwestern.edu) |
| Virginia Commonwealth University Richmond, Virginia | |
| Weill Cornell Medical College New York, New York | June Greenburg - (jdg2002@med.cornell.edu) Koen Van Besien - (kov9001@med.cornell.edu) |